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1 INTRODUCTION 
 
              Redox regulation, like phosphorylation, is a covalent regulatory system that 
controls many of the normal cellular functions of all living cells and organisms. In 
addition, it controls how cells respond to stress involving oxidants and free radicals. 
This area is undergoing a transition from general knowledge to specific description of 
the components and mechanisms involved. A progressive rise of oxidative stress due 
to altered reduction–oxidation (redox) homeostasis appears to be one of the 
hallmarks of the processes that regulate gene transcription in physiology and 
pathophysiology. Reactive oxygen species (ROS) and reactive nitrogen species 
(RNS) serve as signalling messengers for the evolution and perpetuation of the 
inflammatory process that is often associated with the condition of oxidative stress, 
and involves genetic regulation [Halliwell, 1991; Foncea, 2000; Hensley et al, 2000, 
Droege, 2001; Hancock, Desikan and Neill, 2001]. Changes in the pattern of gene 
expression through ROS/RNS-sensitive regulatory transcription factors are crucial 
components of the machinery that determines cellular responses to oxidative/redox 
conditions. In order to study the effect of reactive oxygen species on the expression 
of cardiotrophin-1 (CT-1), we used stem cell derived embryoid bodies as in vitro 
model. 
 
1.1 STEM CELLS 
 
Stem cells are primal undifferentiated cells (self-renewing cells) that have the ability 
to proliferate and differentiate into cell types of different tissues in vitro and in vivo. 
Molecular cues provided by their cellular environment or niche and subsequently 
activated transcriptional factors appear to switch specific genetic programmes on or 
off in a very controlled manner. Execution of the right genetic programme and 
therefore differentiation into specific cell types depends crucially on the availability of 
right combination and sequences of cues [O’Shea, 2004]. Stem cells differ from other 
kinds of cells in the body. All stem cells regardless of their source have three general 
properties: (i) they are capable of dividing and renewing themselves for long periods; 
(i) they are specialised; (iii) they can give rise to specialised cell types. Based on the 
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developmental potential of stem cells, i.e., the number of different kinds of 
differentiated cell that they can become, they are classified as follows (see FIG. 1): 
• Totipotent cells; these cells have the potential to become any cell type in the 
adult body and any cell of the extra embryonic membranes (e.g., placenta). 
The only totipotent cells are fertilised eggs.  
• Pluripotent stem cells; these are cells that have the potential to differentiate 
into any cell in the body, but cannot contribute to making the extra embryonic 
membranes (which are derived from the trophoblast) [Wobus 2001]. Three 
types of pluripotent stem cells have been found  
- Embryonic Stem (ES) Cells. These cells are isolated from the inner 
cell mass (ICM) of the blastocyst — the stage of embryonic 
development when implantation occurs.  
- Embryonic Germ (EG) Cells. These cells are isolated from the 
precursor to the gonads in aborted fetuses. 
- Embryonic Carcinoma (EC) Cells. EC cells are isolated from 
teratocarcinomas, a tumor that occasionally occurs in a gonad of a 
fetus. Unlike the other two, they are usually aneuploid (having one or 
more extra (or fewer) chromosomes than the normal diploid (2n) set 
(e.g., 2n+1, 2n-1)). 
• Multipotent stem cells (adult stem cells); these cells can only differentiate 
into a limited number of types. For example, the bone marrow contains 
multipotent stem cells that give rise to all the cells of the blood but not to other 
types of cells. Multipotent stem cells are found in adult animals; perhaps most 
organs in the body (e.g., brain, liver) contain them where they can replace 
dead or damaged cells. 
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FIG. 1 Types of stem cells [www.bioteach.ubc.ca/ Bioengineering/StemCells/] 
 
A focus of pluripotent stem cell research is the identification of signals that control 
stem cell differentiation and influence lineage specification. The replication of 
signalling events within the embryo, by providing defined signalling molecules in 
culture, may permit the directed differentiation of ES cells toward selected lineages. 
There exist both intrinsic and extrinsic molecular signals that drive stem cell renewal 
–a vital property of stem cells – and differentiation. Key signalling pathways that have 
been implicated in ES cell maintenance and differentiation include the Notch, TGFβ, 
Wnt pathways. A LIF-dependent JAK/STAT3 pathway [Raz et al, 1999; Bader et al, 
2000; Bader et al 2001], and signalling by Nanog and Oct4 transcription factors have 
been shown to maintain ES cell self-renewal, whereas a MEK/ERK signalling 
mechanism prevents ES self-renewal [Burdon, Smith and Savatier, 2002; Saito, Liu 
and Yokoyama, 2004]. In contrast over-expression of Oct4 results in differentiation of 
ES cells into primitive endoderm; whereas over-expression of Nanog leads to a LIF-
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independent ES cell self-renewal. Oct4 and Nanog signalling prevents differentiation 
into trophectoderm and primitive endoderm, respectively (see FIG. 2). The canonical 
Wnt pathway is activated upon binding of the Wnt protein to the Frizzled receptor 
[Rattis et al, 2004, Reya et al 2005]. Activation of the pathway leads to inhibition of 
glycogen synthase kinase-3 (GSK-3), subsequent nuclear accumulation of β-catenin 
and the expression of target genes. Sato and colleagues (2004) used the specific 
inhibitor of GSK-3, 6-bromoindirubin-3’-oxime (BIO), to demonstrate that the 
activation of the canonical Wnt pathway maintains the undifferentiated phenotype in 
ES cells and sustains expression of the pluripotent state-specific transcription factors 
Oct 4, Rex-1 and Nanog. They demonstrated that the process is fully reversible by 
removing BIO thereby leading to the subsequent onset of differentiation processes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 2 Signalling pathways and transcription factors involved in the maintenance, proliferation, survival and 
differentiation of ES cells [adapted from Hearsley and Peterson, 2004] 
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1.1.1 EMBRYONIC STEM CELLS 
 
ES cells are derived from embryos. Specifically, human ES cells are derived from 
embryos that developed from in vitro fertilised eggs and are then donated for 
research purposes with the consent of the donors. The embryos from which human 
embryonic stem cells are derived are typically 4 or 5 days old and are a hollow 
microscopic ball of cells called the blastocysts [Shamblott et al, 1998; Thomson et al, 
1998; Thomson and Marshall, 1998]. Mouse ES cells are isolated from the inner cell 
mass of pre-implantation embryos or blastocyst at day 3.5 of mouse development. 
The blastocyst includes three structures: the trophoblast, which is the layer that 
surrounds the blastocyst; the blastocoel, which is the hollow cavity inside the 
blastocyst; and the inner cell mass (ICM), which is a group of cells at one end of the 
blastocoel and would normally give rise to the embryonic disk of the later embryo 
and, ultimately, the foetus. When the blastocysts are cultured, the outer layer of cells 
attaches to a feeder layer of mitotically inactivated embryonic fibroblasts and 
undifferentiated cells from the inner cell mass spontaneously form clumps [Evans and 
Kaufman, 1981; Martin, 1981]. When this occurs, they are removed gently and plated 
into several fresh cultured dishes. The process of re-plating the cells is repeated 
many times, and is called sub-culturing to yield ES cell lines. Each cycle of sub-
culturing the cells is referred to as a passage. These cells are considered pluripotent 
as they can be maintained indefinitely in the undifferentiated state in culture, and 
when injected back into a blastocyst, have the ability to contribute to all tissues, 
including the germ cells. Maintenance of Es cells in vitro is achieved by co-culture on 
inactivated mouse fibroblast or on gelatinised plates with a differentiation inhibitory 
factor known as LIF [Martin, 1981; Williams et al, 1988]. Once ES cell lines have 
been established, batches of them can be frozen.  
The in vitro differentiation of ES cells provides a basis both for detailed studies of 
developmental mechanisms and for the generation of specific cell types for tissue 
engineering and regenerative medicine applications.  The in vitro differentiation of ES 
cells recapitulates the early processes of development into a variety of endodermal, 
mesodermal, and ectodermal lineages [Guan et al, 1999; Amit et al, 2000]. Both the 
pattern and the efficiency of differentiation are affected by parameters such as ES 
cell density, media components, growth factors and additives and the quality of fetal 
calf serum used. ES cell lines display different developmental properties in vitro. In 
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vitro differentiation requires the removal of differentiation inhibitory factors and the 
development of ES cells in aggregates, called embryoid bodies (EBs) [Doetschman 
et al, 1993; Wartenberg et al, 1998, Desbaillets et al, 2000; Doevendans et al, 2000; 
Dang et al, 2002]. Specialised cells from these germ layers constitute the complex 
assortment of tissues that make up an entire organism (TABLE 1). 
 
 
EMBRYONIC GERM LAYER CELL TYPE 
Neurons 
Oligodendrocytes 
Astrocytes 
Ectoderm 
Epithelial cells 
Adipocytes 
Cardiomyocytes 
Chondrocytes 
Hematopoietic (stem) cells 
Endothelial cells 
Osteoblasts 
Mesoderm 
Striated- and Smooth- muscle cells 
Pancreatic-like islets 
Insulin-producing cells 
Lung cells 
Endoderm 
Hepatocytes 
TABLE 1 Differentiation of mouse embryonic stem cells in vitro [adapted from Faulkes S.Minireview. 
www.stemcell.com] 
 
 
1.1.2 ADULT STEM CELLS 
An adult stem cell is an undifferentiated cell found among differentiated cells in a 
tissue or organ, can renew itself, and can differentiate to yield the major specialized 
cell types of the tissue or organ. The primary roles of adult stem cells in a living 
organism are to maintain and repair the tissue in which they are found. Unlike 
embryonic stem cells, which are defined by their origin (the inner cell mass of the 
blastocyst), the origin of adult stem cells in mature tissues is unknown. Adult stem 
cells have been identified in many organs and tissues. They are thought to reside in 
a specific area of each tissue where they may remain quiescent for many years until 
they are activated by disease or tissue injury. As of now the following adult tissues 
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have been reported to contain resident stem cells: brain, bone marrow [Iscove, 1990; 
Mackay et al, 1998; Pittenger et al, 1999; Orlic et al, 2001], blood [Hall et al, 1989; 
Juttner et al, 1989; Kessinger et al 1991], skeletal muscle, skin, heart [Anversa et al, 
2002], fat and liver.  
 
Not so long ago, it was thought that only embryonic stem cells could generate all 
different cell types in mammalian body, and that adult stem cells are more restricted 
in their developmental potential. However, it has recently been shown that adult stem 
cells exhibit the ability to form specialized cell types of other tissues, which is known 
as transdifferentiation or plasticity (see FIG. 3) [Bjornson et al, 1999; Makino et al 
1999; Goodell et al, 2001; Jackson et al, 2001; Orlic et al, 2001]. 
HEMATOPOIETIC STEM CELLS
brain cells
skeletal muscle cells cardiac muscle cells
liver cells
BONE MARROW STROMAL CELLS 
skeletal muscle cells cardiac muscle cells
BRAIN STEM CELLS
skeletal muscle cells blood cells
                           
FIG. 3 Adult Stem Cell Plasticity And Transdifferentiation 
 
In the past few years many scientists have been trying to find ways to grow adult 
stem cells in cell culture and manipulate them to generate specific cell types so they 
can be used to treat injury or disease. Some examples of potential treatments include 
replacing the dopamine-producing cells in the brains of Parkinson's patients, 
developing insulin-producing cells for type I diabetes and repairing damaged heart 
muscle following a heart attack with cardiac muscle cells. If successful, adult stem 
cell therapy will help to solve the ethical conflicts that exist with the ES cells. An 
advantage of adult stem cells is that, potential ethical issues and immunogenic 
rejection are averted, since they can be harvested from the patient. 
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1.1.3 STEM CELL MARKERS 
 
While stem cells are best defined functionally, a number of molecular markers have 
been used to characterise various stem cell populations. 
 
Embryonic stem cell markers 
 
• Oct-4: Oct-4 (also termed Oct3 or Oct3/4), one of the POU transcription 
factors, was originally identified as a DNA-binding protein that activates gene 
transcription via a cis-element containing octamer motif. It is expressed in 
totipotent ES- and EG- cells. A critical level of Oct-4 is required to sustain stem 
cell self-renewal and pluripotency. Differentiation of ES cells result in down-
regulation of Oct-4, an event essential for a proper and divergent development 
program [Scholer et al, 1989; Rosner et al, 1990; Niwa, Miyazaki and Smith, 
200]. Oct-4 is not only master regulator of pluripotency that controls lineage 
commitment, but is also the first and most recognised marker used for the 
identification of totipotent ES cells. 
• SSEAs (Stage Specific Embryonic Antigens): SSEAs were originally identified 
by the three monoclonal antibodies recognising defined carbohydrate epitopes 
associated with the lacto- and globo- series glycolipids, SSEA-1, -3 and -4. 
Undifferentiated murine pluripotent cells express SSEA-1 and do not exhibit 
any reactivity to the SSEA-3, SSEA-4 monoclonal antibodies. Following 
differentiation, murine EC and ES cells exhibit a decrease in the expression of 
SSEA-1 and an increase in the expression of SSEA-3 and SSEA-4 [Thomson 
et al, 1998; Thomson and Marshall, 1998]. In contrast, undifferentiated human 
EC, ES and EG cells express the antigens SSEA-3, SSEA-4. Differentiation of 
human EC and ES cells is characterized by an increase in SSEA-1 expression 
and a down regulation of SSEA-3 and SSEA-4. Unlike human EC and ES 
cells, only EG cells express SSEA-1. 
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ADULT STEM CELL MARKERS 
 
In TABLE 2 below is a list of markers which are used to identify adult stem cells from 
hematopoietic [Sutherland et al, 1992; Spangrude and Brooks, 1993; Yu et al, 2002; 
Zhou et al, 2001], neural [Frederiksen et al, 1988; Mayer-Proschel et al, 1997; 
Morrison et al, 1999] and mesenchymal [Simmons and Rorok-Storb , 1991] origin. 
 
STEM CELL TYPE MARKERS 
Hematopoietic stem cell  - CD34 
- CD133 
- stem cell antigen 1, Ly-6A/E (Sca-1) 
- ATP-binding cassette superfamily G member 2 
(ABCG2) 
 
Mesenchymal stem cell STRO-1 
Neural stem cell -  p75 Neurotrophin R (p75 NTR) 
- Polysialic acid-neural cell adhesion molecule 
(PSA-NCAM) 
- Nestin 
   TABLE 2 Adult Stem Cell Markers. 
 
Since the initial derivation of mouse ES- cells in the early 1980s [Evans and 
Kaufman, 1981; Martin, 1981], the in vitro differentiation capacity of ES cells has 
provided a unique opportunity for experimental analysis of gene regulation and 
function during cell commitment and differentiation in early embryogenesis, and a 
potential source of cells for replacement following injury or disease. ES cells have 
also provided a platform to study pathways of differentiation and maintenance of 
pluripotency that are likely to have broad applications to the field of stem cell biology, 
cancer stem cell biology, and the understanding of how development may go awry. 
In this project embryoid bodies (EBs) derived from mouse ES cell lines were used to 
study the effect of intracellular redox state in the expression of CT-1 during the 
differentiation of ES cells. 
 
 
 
INTRODUCTION 
  10
1.2 INTRA-CELLULAR REDOX STATE AND REDOX SIGNALLING 
 
Free radicals and other ROS play a very important role in many cells/organisms. 
They are involved in many (patho-) physiological processes in the cell/organism. 
Every living organism possesses numerous cellular antioxidant systems to control the 
amount of free radicals and ROS available in the cellular system and maintain the 
redox balance of the cell (see FIG. 4). A shift in the equilibrium between free 
radicals/ROS and these control mechanism leads to oxidative stress. Free radicals 
are a cluster of atoms that contain an unpaired electron in their outermost orbit of 
electrons. This is an extremely unstable configuration, and radicals quickly react with 
other molecules or radicals to achieve the stable configuration. Most biological 
molecules are nonradicals containing only paired electrons. 
 
1.2.1 SOURCES OF ROS 
 
The main source of ROS is the mitochondrion which converts about 2% of consumed 
molecular oxygen into superoxide anion (O2.-) during mitochondrial respiration. 
Mitochondrial respiration converts carbohydrates into high-energy metabolites such 
as adenosine triphosphate (ATP). This requires the sequential oxidation and 
reduction of the substrates using respiratory complexes. After oxidation by 
mitochondrial and plasma membrane oxidases, oxygen is reduced and the 
superoxide radical is formed. Other sources for O2.- generation include NADPH 
oxidase, lipooxygenase, hypoxanthine/xanthine oxidase, cyclooxygenase [Droge, 
2002]. O2. - is a relatively short-lived ROS and is converted to hydrogen peroxide 
(H2O2) by superoxide dismutase (SOD) (equation 1-3), and H2O2 is degraded to 
water by several cellular enzymes such as catalase and glutathione (GSH) 
peroxidase. Reaction of O2.- with NO. generates peroxynitrite, a potentially 
deleterious ROS (equation 4). 
 
                                      O2     +    e-              O2.-                             (1) 
                                  2O2  + NADPH    2O2.-  + NADP+  +  H+             (2) 
                                  2O2.-  + H+            H2O2  + O2                         (3) 
                                     NO.  +  O2.-    OONO-                                  (4) 
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H2O2 is also produced in the thyroid gland as a substrate for thyroperoxidase, which 
catalyzes the attachment of iodine to thryoglobulin, an important protein for the 
synthesis of thyroid hormone. H2O2 is generated in peroxisomes to aid in the 
degradation of fatty acids and other molecules, and H2O2 is used for detoxification 
reactions involving the liver cytochrome P-450 system. H2O2 can also react with 
reduced transition metals (Me) or semiquinones through the Haber-Weiss- or Fenton 
reactions [Stadtman and Berlett, 1998] to be converted to the highly reactive hydroxyl 
radical (.OH) as shown in equation 5, or it can be metabolized by myeloperoxidase 
(MPO) to form hypochlorous acid (HOCl). 
 
                             H2O2  + Me(n-1)   .OH  +  OH-  +  Me(n)                  (5) 
                    e.g.  H2O2+ Fe2+ or Cu+  .OH + OH- + Fe3+ or Cu2+ 
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FIG. 4 Schematic presentation of sources of ROS and antioxidant defence system. The levels of intracellular 
ROS are balanced by the intracellular antioxidant defence system which consists of enzymatic and nonenzymatic 
components.  
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Some cells, such as phagocytic leukocytes, have evolved the use of H2O2 as a 
bactericidal defense chemical, a phenomenon known as oxidative burst. In these 
inflammatory cells, NADPH oxidase associated with the plasma membrane reduces 
molecular oxygen to generate O2.-. O2.- is spontaneously or enzymatically converted 
to H2O2 which can then freely pass through the membrane. While these oxidants are 
important in protecting us from infection, they can cause oxidative damage during 
chronic inflammatory activity [Halliwell, 1991; Bruene et al, 2003; Kreeger, 2003]. 
Oxidative stress is caused by an excessive accumulation of ROS as a result of a 
defective antioxidant defense system of the cell (see FIG. 5).Oxidative stress can 
generally be imposed on cells as a result of one of three factors: 
1) an increase in oxidant generation, 
2) a decrease in antioxidant protection, 
3) a failure to repair oxidative damage. 
The importance of oxidative stress is that it increases the susceptibility of cellular 
constituents to oxidative molecular damage such DNA fragmentation, lipid 
peroxidation, activation of oncogenes or repression of tumor suppressor genes and 
release of Ca2+ within the cells, leading to the activation of Ca2+-dependent proteases 
and nucleases. Inflammatory processes often overshoot in their reaction leading to 
excessive production of ROS, destruction of healthy body tissue, and development of 
auto-destructive disease. The relationship of oxidative stress and inflammation is 
undisputed. Mounting evidence points to chronic inflammation as not only being the 
problem of well recognized inflammatory diseases such as tuberculosis, rheumatoid 
arthritis or inflammatory bowel disease [Hensley et al, 2000], but also as a contributor 
to a growing number of mechanistically unconnected illnesses such as 
atherosclerosis, Alzheimer disease, aging and some cancers [Beckman & Ames, 
1998; McNally et al, 2003; Forrester, 2004].  
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FIG. 5 Schematic illustration of the cellular impact of ROS. At low concentrations, ROS appear to exert a 
growth-stimulatory effect on a wide variety of cells and organisms. However, when ROS levels increase, other 
signaling pathways may be activated that lead to apoptosis. When ROS levels rise even higher, a cell will 
probably die a sudden necrotic death. Only the latter 2 modes of ROS action are currently being considered to be 
due to “oxidative stress.” [Adapted from Buetler et al, 2004] 
 
1.2.2 REDOX SIGNALLING 
 
Signal transduction is an event of conversion of signals from extracellular stimuli 
carried by first messengers such as hormones, growth factors, cytokines, and 
neurotransmitters across plasma membranes to intracellular responses that lead to 
changes in gene expressions and cellular phenotypic modulations. 
Evidence is rapidly accumulating to suggest that intracellular oxidation-reduction 
(redox) reactions play a critical role in the regulation of several (patho) physiological 
processes including cell proliferation, senescence, differention, and apotosis. ROS 
including O2.-, H2O2, .OH, and organic hydroperoxides are continuously generated by-
products of O2 metabolism and have traditionally been thought of as unwanted and 
toxic by-products of living in aerobic environment. The long held view that ROS is 
detrimental to the biological tissue was challenged after recent discovery that ROS 
can function as signalling molecules. An important feature of the signal transduction 
is that the first messenger molecules need not enter the cell and their biological 
effects are mediated inside the cell by second messenger molecules such as cAMP, 
cGMP, inositol 1,4,5-trisphosphate (Ins 1,4,5-P3), nitric oxide, and 
phosphatidylinositol 1,3,4,5-tetrakisphosphate (PtdIns 1,3,4,5-P4) (pioneered by the 
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work on cAMP by Earl W. Jr. Sutherland Recipient of the 1970 Nobel Prize in 
Physiology and Medicine). The second messenger generation processes involve 
various cellular components, like specific receptors, transducers, adaptor proteins, 
protein kinases, and protein phosphatases, and eventually lead to the induction of 
physiological responses. ROS fulfil the definition of secondary messenger, which are 
either up-regulated or down-regulated after physiologic stimuli. ROS have been 
shown to be generated in a wide variety of cell types stimulated by hypoxia [Chandel 
et al, 1998; Duranteau et al, 1998; Chandel et al, 2000; Kulisz et al 2002; Schäfer et 
al, 2003],  cytokines such as tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), 
interleukin-1,-6 (IL-1, IL-6), and angiotensin II (Ang II) [Ohba et al., 1994; Thannickal 
and Fanburg, 1995; Meier et al.,1989; Lo, Wong and Cruz, 1996; Lassegue et al, 
2001],  growth factors [Krieger-Brauer and Kather, 1995; Sundaresan et al., 1995; 
Lo, Wong and Cruz, 1995; Bae et al., 1997; Irani et al, 1997; Chandel et al, 2001; 
Park et al, 2004], and other agonist acting through tyrosine kinase and G protein-
coupled receptors [Krieger-Brauer and Kather, 1995; Sundaresan et al., 1995; Bae et 
al., 1997; Lo, Wong and Cruz, 1996].  
 
The mitogenic signals mediated through the generation of ROS activate transcription 
factors including NF-kB [Schreck et al., 1991] and AP-1 [Pahl and Baeuerle, 1994; Lo 
and Cruz, 1995; Diamond et al, 1999], HIF-1α [Chandel et al, 1998; Chandel et al, 
2000; Sauer, Wartenberg and Hescheler, 2001; Soberman, 2003], mitogen-activated 
protein [MAP] kinases [Chen et al., 1995; Sundaresan et al., 1995; Guyton et al, 
1996; Hashimoto et al, 2001; Haddad and land, 2002; Blanc et al, 2003; Gorin et al, 
2004], phospholipase A2 [Zor et al., 1993], protein kinase C [Konishi et al., 1997], 
phosphatidylinositol 3-kinase [ Sauer et al, 2000; Park et al, 2004] and phospholipase 
D [Natarajan et al., 1993; Min et al., 1998]. Furthermore, ROS increase cytosolic 
calcium [Suzuki et al., 1997], trigger apoptosis [Jacobson, 1996], inhibit protein 
tyrosine phosphatases [PTPase] [Hecht and Zick, 1992; Sullivan et al., 1994; Lee 
and Esselman, 2002], and alter ion transport mechanisms [Kourie, 1998]. A further 
feature of ROS is that they regulate the expression of antioxidant enzymes like 
thioredoxin system [Arner and Holmgren, 2000; Mustacich and Powis, 2000; Zhao 
and Holmgren, 2002], superoxide dismutase [Decraene et al, 2004] catalase, 
glutathione peroxidase and small anti-oxidant molecules like α-tocopherol, lipoic acid, 
ascorbic acid, and uric acid and the antiapoptotic protein BCL2.  
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1.2.3 REDOX SIGNALLING IN THE CARDIOVASCULAR SYSTEM 
 
ROS are important signalling molecules in the vasculature, acting as intermediates in 
biochemical pathways involved in processes ranging from acute vasodilation to 
vascular growth and remodelling. Although it is well established that NADPH oxidase 
is the major source of ROS in the artery wall, it still remains unclear which isoform (s) 
of this enzyme contributes to ROS production during normal physiology and 
importantly, to the oxidative stress associated with many vascular diseases [Byrne, 
2003]. In vascular cells ROS are known to mediate the K+ channel-opening and 
vasodilation effects of bradykinin and other endothelium-dependent relaxing 
agonists. ROS also regulate long-term vasculature processes, such as cell growth 
and division, by acting as second messengers for the effects of growth factors such 
as angiotensin II and platelet-derived growth factors [Sundaresan et al, 1995], 
thrombin and cytokines such as TNF-α and IL-1 [Meier et al, 1989], protein kinases 
and transcription factors and on gene expression. It has been shown, using the stem 
cell-derived EBs model [Wartenberg et al, 1998] that ROS stimulate and promote 
cardiomyogenesis. This effect is attenuated with antioxidants and NADPH oxidase 
inhibitors [Sauer et al, 2000; Sauer et al, 2004]. 
 
Under patho-physiological conditions, ROS have the potential to cause cellular 
damage and dysfunction. Whether the effect is beneficial or harmful will depend upon 
site, source and amount of ROS produced, and the overall redox status of the cell. All 
cardiovascular cell types are capable of producing ROS, and the major enzymatic 
sources in heart failure are mitochondria, xanthine oxidases, and non-phagocytic 
NADPH oxidases (Noxs) [Griendling, 1997; Lassegue et al, 2001; Kulisz et al, 2002; 
Suzuki and Griendling, 2003]. In addition to their effects on cellular enzymatic and 
protein function, ROS have been implicated in the development of agonist-induced 
cardiac hypertrophy, cardiomyocyte apoptosis and remodelling of the failing 
myocardium. ROS production in the artery wall has been shown to increase so that 
the anti-oxidant systems are overwhelmed in vascular diseases such as 
hypertension, diabetes and atherosclerosis [Sorescu et al, 2002]. This shift in 
equilibrium between ROS production and elimination, leads to oxidative stress, a hall 
mark of virtually all vascular patho-physiological states. ROS have been implicated 
as a major cause for the pathogenesis of myocardial ischemia [Sudgen and Clerk, 
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1998] and reperfusion injury.  These alterations in phenotype are driven by redox-
sensitive gene expression, and in this way ROS act as potent intracellular second 
messenger. Despite advances in treatment, chronic congestive heart failure carries 
poor prognosis and remains a leading cause of cardiovascular death. Accumulating 
evidence suggests that ROS play an important role in the development and 
progression of heart failure, regardless of the ethiology. Keith and colleagues (1998) 
found in a clinical study with 58 patients a progressive increase in lipid peroxidation, 
and a reduction in antioxidant reserve with the progression of congestive heart failure 
(CHF). Mallat and colleagues (1998) also reported an increase in levels of 9-iso-
prostaglandin F2α, a marker of oxidative stress, in the pericardial fluid of CHF patients 
undergoing surgery, which are closely related with NYHA functional class and left 
ventricular (LV) chamber dimensions. Cardiac hypertrophy is a compensatory 
response that allows the heart to cope with the pathogenic stimuli found in many 
cardiovascular diseases. Cardiac hypertrophy occurs in response to diverse stimuli, 
including mechanical stress [Komuro et al, 1990; Sadoshima and Izumo, 1993; An et 
al, 1999; Aikawa et al, 2001; Sugden, 2001; Sugden, 2003], and neurohormonal 
stimuli such as angiotensin II [Ushio-Fukai et al, 1996; Griendling et al, 2000; 
Lassegue et al, 2001; Sadoshima et al, 1993], endothelin-1 [Yamazaki et al, 1996] 
and norepinephrine [Zimmer et al, 1995] The functional importance of ROS in 
cardiovascular cells has been most widely studied in VSMCs where O2.-, H2O2 and 
.OH- have been shown to be prohypertrophic [Ushio-Fukai et al, 1998; Finkel, 1999; 
Griendling et al, 2000; Aikawa et al, 2001]. The treatment of neonatal rat ventricular 
myocytes with vitamin E, N-acetylcysteine, N-2-mercaptopropionyl-glycine and 
catalase completely inhibited angiotensin II and TNF-α induced myocyte hypertrophy 
[Nakamura et al, 1998; Aikawa et al, 2001; Xiao et al, 2002]. Laursen and colleagues 
(1997) showed that angiotensin II-induced hypertension was associated with 
increased vascular O2.- production and that treatment with SOD reduced blood 
pressure by 50 mmHg in angiotensin II-infused rat. In addition, Hamaguchi and 
colleagues (1998) reported that the increase in MAP kinase activity was sustained in 
the angiotensin II-infused rat. These findings suggest that hypertension caused by 
chronically elevated angiotensin II and MAP kinase activity is mediated in part by O2.-
. Increases in ROS may affect the pathogenesis of atherosclerosis. 
Hypercholesterolemic animals and patients exhibit impaired endothelial dependent 
relaxation that can be restored with antioxidants. It was clinically observed that 
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vascular superoxide production by NADH/NADPH oxidase is associated with 
endothelial dysfunction in patients with hypercholesterolemia [Guzik et al, 2000; 
Djordjevic et al, 2005]. Vessel remodeling is also a ROS-sensitive process. It was 
reported that p22phox, a component of NADH/NADPH oxidase, expressed highly in 
atherosclerotic remodeled specimens of the coronary artery. It should be noted that 
NADH/NADPH oxidase is a potent mediator of MAP kinase activation. Recent 
findings revealed that remodeling occurs in patients after the PTCA procedure and 
remodeling is a key process for restenosis. In vivo experiment have shown that 
antioxidants inhibit restenosis implying the role of ROS in vascular remodelling 
[Azumi et al, 1999; Mintz et al, 1996, Numes et al, 1995; Tardif et al, 1997]. 
1.2.4 VASCULAR NADPH-OXIDASES 
The major sources of ROS in the vasculature, the vascular NAD(P)H oxidases, are 
similar in structure to the phagocytic NADPH oxidase, which consist of 4 major 
subunits: a cytochrome b558, comprising of a large catalytic β-subunit, gp91phox 
that contains binding sites for NADPH and molecular oxygen, as well as flavin and 2 
heme groups to allow electron transport between the two substrates and a smaller α-
subunit, p22phox. The cytoplasmic protein complex is composed of p47phox, 
p67phox and p40phox, and a regulatory low-molecular weight G protein rac. The 
function of p40 subunit which is not essential for oxidase activity is still to be clarified. 
In order to be activated, the oxidase requires the translocation of the cytoslic 
components to the membrane (see FIG. 6). There exist at least three isoforms of 
NADPH oxidase expressed in the vascular wall, each differing with respect to the 
flavin-containing catalytic subunit it uses to transfer electrons from NADPH to 
molecular oxygen. Thus, although endothelial cells and adventitial fibroblasts express 
a gp91phox-containing NADPH oxidase (Nox2) similar to that originally identified in 
phagocytes, vascular smooth muscle cell and cardiomyoctes may rely on homologes 
of gp91phox, namely Nox1 [Suh et al, 1999; Bànfi et al, 2000; Sorescu et al, 2004] 
and Nox4 [Geiszt et al, 1997; Shiose et al, 2001] to produce superoxide. Other Noxs 
have been found in non-vascular cells, these include Nox3 [Cheng et al, 2001; 
Lambeth, 2004] found in embryonic kidney, Nox5 which is distinguished from the 
other family members by its longer N-terminus and is found in testis, B- and T-
lymphocyte-rich area of spleen and lymph nodes, Duox1 and Duox2 with an 
additional peoxidase domain [Krause et al, 2004; Harper et al, 2005]. Duox1 is found 
in thyroid and lung, and Duox2 in thyroid and colon. 
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FIG. 6 Generation of O2.- and H2O2 from O2 in vascular cells. Many enzyme systems, including NAD(P)H 
oxidase, xanthine oxidase, and uncoupled nitric oxide synthase (NOS) among others, have the potential to 
generate ROS. Superoxide acts either as an oxidizing agent, where it is reduced to H2O2 by SOD, or as a 
reducing agent, where it donates its extra electron (e_) to form ONOO_ with NO. Hydrogen peroxide is 
scavenged by catalase, glutathione and thioredoxin systems, and can also be reduced to generate ·OH in the 
presence of Fe2+ [Touyz and Schiffrin, 2004]. 
 
1.2.5 HYPOXIA, HIF-1α REDOX SIGNALLING 
In order to achieve oxygen homeostasis, a process that is essential for survival, pO2 
delivery to the mitochondrial electron transport chain must be tightly maintained 
within a narrow physiological range. This system may fail with subsequent induction 
of hypoxia, resulting either in a failure to generate sufficient ATP to sustain metabolic 
activities or in a hyperoxic condition that contributes to the generation of ROS, which 
in excess could be cytotoxic. Variation in ∆pO2 in particular, differentially regulates 
the compartmentalisation and functioning of transcription factors such as hypoxia-
inducible factor-1α (HIF-1α) and nuclear factor-kappa B (NF-κB). Oxygen-evoked 
regulation of HIF-1α and NF-κB is closely coupled with the intracellular redox state, 
such that modulating redox equilibrium affects their responsiveness at the molecular 
level (expression/transactivation). Hypoxia initiates transcription of a number of gene 
products that help to sustain the supply of O2 to tissues and to enhance cell survival 
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during severe O2 deprivation. The induction of these genes is mediated by hypoxia-
inducible factor 1 (HIF-1), a heterodimeric transcription factor consisting of HIF-1α, 
and the aryl hydrocarbon nuclear translocator (ARNT or HIF-1β) subunits, both 
belonging to the basic helix-loop-helix Per-aryl hydrocarbon receptor nuclear 
translocator Sim (PAS) family of transcription factors (see FIG 7) [Chun, Kim and 
Park, 2002; Wang et al, 1995; Semenza, 2001; Semenza, 2002].  
 
 
FIG 7 HIF-1α and HIF-1β subunits. HIF-1α and HIF-1β contain one basic–helix–loop–helix (bHLH) domain 
and two PER–ARNT–SIM (PAS1 and PAS2) domains in their N-terminal regions. The positions of post-
translational hydroxylation (OH) and acetylation (OAc) sites of HIF-1α are indicated. Hydroxylation of two 
proline residues (at P402 and P564) and acetylation of lysine (at K532) within the oxygen dependent degradation 
(ODD) domain (residues 401–603) and close to the N-terminal transactivation domain (NTAD) confers 
recognition by pVHL (the product of the von Hippel–Lindau tumour suppressor gene), leading to degradation of 
the α-subunit. Hydroxylation at N803 in the C-terminal transactivation domain (CTAD) of HIF-1α inhibits 
recruitment of coactivators required for HIF1α transcriptional activity. HIF-1α contains one transactivation 
domain (TAD) in its C-terminus. [www-ermm.cbcu.cam.ac.uk/ 05009130h.htm] 
 
HIF-1 binds to the core DNA sequence 5'-[AG]CGTG-3' within the hypoxia response 
element (HRE) of target gene promotors. Activation requires recruitment of 
transcriptional coactivators such as CREB-binding protein (CBP) and p300. 
Since its original description, the study of the transcription factor HIF-1 has 
demonstrated its central role in regulating the body’s response to changing oxygen 
levels. HIF-1 is a key component of a widely operative transcriptional response 
activated by hypoxia, cobaltous ions, and iron chelation. HIF-1α, first identified in vitro 
through its DNA-binding activity expressed under hypoxic conditions, has its 
concentration and activity increased exponentially when oxygen tensions are 
decreased over physiological relevant ranges (hypoxia). The ubiquitous activity of 
HIF-1α is thus consistent with the significant role that it plays in coordinating adaptive 
responses to hypoxia [Wang and Semenza, 1995; Jewell, 2001; Semenza, 2001; 
Lutz and Prentice, 2002; Page, 2002]. It is the paradigm for how molecular oxygen 
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can regulate transcription. The functions of HIF-1 target genes have been divided 
into categories that include cell proliferation and viability, erythropoiesis and iron 
metabolism, as well as vascular development and remodeling. The expression of 
these genes is induced when oxygen tension decreases over physiological relevant 
ranges. To prevent the continuous overexpression of these genes, cells utilize prolyl 
hydroxylases [Hofer et al, 2001; Elkins et al, 2003; Huang and Bunn, 2003] to 
hydroxylate HIF-1α. Hydroxylation targets HIF-1α for binding to the von Hippel-
Lindau protein (pVHL), which is the recognition component of an E3 ubiquitin protein 
ligase, and ubiquitination of HIF-1α. These results in the targeting of HIF-1α for 
destruction by the proteasome. Cells lacking functional pVHL cannot degrade HIF 
and thus overproduce mRNAs encoded by HIF target genes. Oxygenation of 
asparagine also blocks the recruitment of coactivating proteins [Lando et al, 2002].  
 
Many researchers have shown that there is an increase in intracellular ROS levels 
during hypoxia [Chandel et al, 1998; Duranteau et al, 1998; Kulisz et al, 2002; 
Schaefer et al, 2003], indicating that redox signaling pathways may be involved in the 
regulation of hypoxia responsive genes. This hypothesis was supported by the fact 
that pro-oxidants, that induce an increase in intracellular ROS, stabilized and 
activated HIF-1α leading to the increased expression of various genes [Duyndam et 
al, 2001; Haddad and Land, 2001; Gao et al, 2002]. 
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1.3 CARDIOTROPHIN-1 AND INTERLEUKIN-6 SUPERFAMILY 
1.3.1 INTERLEUKIN-6 SUPERFAMILY AND RECEPTOR-COMPLEXES 
 
 CT-1 is member of the cytokine family known as the IL-6 superfamily that also 
includes interleukin-6 (IL-6), interleukin-11 (IL-11, leukaemia-inbibitory factor (LIF), 
Oncostatin M (OSM), cardiotrophin-like cytokine (CLC) and ciliary neurotrophic factor 
(CNTF). CT-1 has overlapping functions with other IL-6 family members in a variety 
of cell types [Pennica et al, 1995]. Since the molecular cloning of IL-6 in 1986, 
members of the IL-6 family of cytokines, LIF, CNTF, OSM, IL-11 and CT-1 have been 
molecularly cloned. During the last decade, many findings have been made 
concerning the structure and function of IL-6 family cytokines and their receptors. 
These findings, together with a large number of studies on many cytokines, have 
greatly contributed to the establishment of a variety of concepts about these 
cytokines in general: the establishment of pleiotropy and redundancy as properties of 
cytokine function, the cytokine receptor superfamily, the sharing of a signal-
transducing receptor subunit among several cytokine receptors (see FIG. 8 ), and the 
agonistic activity of certain soluble cytokine receptors. In fact, the IL-6 cytokine family 
plays pivotal roles in the immune, hematopoietic, nervous, cardiovascular, and 
endocrine systems, as well as in bone metabolism, inflammation, and acute phase 
response. Furthermore, they often exert overlapping biological activities; the 
molecular mechanism of this functional redundancy is explained at least in part by 
the sharing of gp130, a signal-transducing receptor subunit among the receptors for 
the IL-6 cytokine family. Important questions yet to be resolved are: how a single 
cytokine can exert functional pleiotropy and how it can induce only a specific 
biological activity in a given target cell. Another important receptor that plays a role in 
the signalling by members of the IL-6 superfamily of cytokines is the LIFR. These 
cytokines relay their signals into the cells either by homodimerisation of gp130R (like 
in the case of IL-6, IL-11) or heterodimerisation of the LIFR and gp130R (LIF, CT-1, 
CNTF) [Taga et al, 1997; Heinrich et al, 1998; Hermans et al, 1999]. In the case of 
OSM, a third receptor has been cloned i.e. the OSMR [Mosley et al, 1996]; the 
receptor combination depends on the type of tissue (either LIFR and gp130R or 
OSMR and gp130R). Robledo and colleagues in 1997 reported the existence of a 
third receptor for CT-1. This receptor is highly glycosylated and has a molecular 
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weight of about 80 kDa (gp80). It is postulated that the gp80R regulates the cell 
specifity and sensitivity of CT-1, since it is not expressed in all cell types that express 
the LIFR.  
 
  
FIG. 8 Receptor complexes of IL-6-type cytokines. IL-6-type cytokine receptor complexes signal through 
different combinations of the signalling receptor subunits gp130, LIFR and OSMR, with gp130 being used by all 
the family members [Heinrich et al, 1998]. 
 
1.3.2 CARDIOTROPHIN-1  
CT-1 was discovered by Pennica and colleagues (1995) via expression cloning of 
mouse embryoid bodies, using a cardiac myocyte hypertrophy screen to identify 
positive clones. The mouse CT-1 protein contains 203 amino acids and shares 80% 
amino acid homology with the human 201-amino acid CT-1 sequence however, 
unlike the mouse CT-1, the human CT-1 protein has 2 rather than 1 cys and has no 
N-gylcosylation site. They reported that the mouse CT-1 gene constitutes 5.4 
kilobases (kb) in length and consists of three exons and two introns. When nucleotide 
sequences of the coding regions of exons were compared with those of human exon 
1, 2 and 3, they were shown to share 96%, 84% and 81% homology, respectively. 
The amino acid sequence of CT-1 has some 24% identity and 19% identity with that 
of LIF and CNTF, respectively (see FIG. 9). While members of the IL-6 superfamily 
are only distantly related in primary sequence (15-20% amino acid identity), they are 
predicted to have similar tertiary structures containing four amphipathic helices. 
Analysis of the helices predicted for CT-1, based on the sequence alignment (see 
FIG. 9), indicates that they are amphipathic, as would be expected for a member of 
this family. CNTF, like CT-1, lacks a hydrophobic N-terminal secretion signal 
sequence. Funamoto and colleagues (2000) isolated and characterized the mouse 
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CT-1 gene. They showed that the 2.2 kb of 5 flanking region of the mouse CT-1 gene 
contains a variety of transcription factor binding motif (e.g. CREB, HIF-1, MyoD, NF-
IL6, Nkx2.5, and GATA). Fluorescent in situ hybridization (FISH) analysis 
demonstrated that the mouse CT-1 gene was located on chromosome 7F3.  
 
 
FIG. 9 Encoded amino acid sequence of mouse CT-1 (mCT-1) aligned with that of mouse LIF (mLIF) and 
mouse CNTF (mCNTF). Overlining indicates the location of four amphipathic helices based on their proposed 
locations in CNTF. As a quantitative measure of their amphipathic character, the mean helical hydrophobic 
moments ((ILH)) for the four CT-1 segments (maximum of 18 residues) are 0.59, 0.34, 0.59, and 0.34 for 
helicesA-D, respectively. [Pennica et al. 1995] 
 
CT-1 is a pleiotropic cytokine which is highly expressed in heart, skeletal muscle, 
prostate and ovary and to lower levels in lung, kidney, pancreas, thymus, testis and 
small intestine [Asai et al, 2000]. CT-1 signals through the LIF receptor and the 
gp130 receptor subunit. The LIF receptor binds CT-1, and then gp130 associates 
with the ligand-receptor complex and transduces the proximal signal. CT-1 
intracellular signaling pathways include extracellular signal regulated kinases (ERK), 
mitogen activated protein (MAP) kinases, the janus kinase (JAK)/signal transducers 
and activators of transcription (STAT) system, and PI3-kinase/Akt. Downstream 
mediators of CT-1’s cellular effects include multiple ERK-coupled transcription 
factors, STAT-3, nuclear factor-κB, and heat shock proteins 56, 70, and 90 [Freed et 
al, 2005; Funamoto et al, 2000; Kunisada et al, 1998; Kuwahara et al, 2000; Robledo 
et al, 1997; Pennica et al, 1996; Yasukawa et al, 2001]. CT-1 has the ability to induce 
cardiac myocyte hypertrophy, and enhances the survival of cardiomyocyte (see FIG. 
10 for mechanisms involved). CT-1 promotes cardiac myocyte hypertrophy by 
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directing sarcomere assembly in series through gp130 signalling [Wollert et al. 1996]. 
At the ventricular structural level, in-series sarcomeric assembly leads to “eccentric” 
hypertrophy and chamber dilation. CT-1 has been shown to be elevated in the serum 
of patients with ischemic heart disease, including unstable angina pectoris [Talwar et 
al, 2000], myocardial infarction [Takimoto et al, 2002], and heart failure [Jougasaki et 
al, 2000; Talwar et al, 2000; Zolk et al, 2002]. CT-1 has also a neurotrophic function 
[Li et al, 2003; Sakamoto et al, 2003]. Oppenheim and colleagues (2001), reported 
that CT-1 deficiency causes increased motoneuron cell death in spinal cord and 
brainstem nuclei of mice during a period between embryonic day 14 and the first 
postnatal week. Bordet and colleagues (2001) reported that intramuscular injection of 
an adenoviral vector encoding CT-1 in SOD1G93A newborn mice resulted in 
systemic delivery of CT-1, supplying motor neurons with a continuous source of 
trophic factor. Furthermore, they showed that CT-1 delayed the onset of motor 
impairment. CT-1 is a hepatocyte survival factor that efficiently reduces 
hepatocellular damage in animal models of acute liver injury [Robledo et al, 2003]. 
Richards CD and colleagues (1996), showed that murine CT-1 is a strong acute-
phase mediator for rat hepatocytes in vitro and that its activity is similar to LIF on rat 
hepatocytes, H35 cells, and HepG2 cells. CT-1 expression has been shown to be 
augmented after hypoxic stimulation, and it can protect cardiac cells when added 
either prior to simulated ischemia or at the time of reoxygenation following simulated 
ischemia (Liao et al, 2002; Bristow and Long, 2002). CT-1 also can induce 
expression of protective heat shock proteins (Hsps) in cardiac cells. CT-1 increased 
ventricular expression of atrial natriuretic peptide (ANP), brain natriuretic peptide 
(BNP) and angiotensinogen mRNA [Ishikawa et al, 1999].  So far, the molecular 
regulation of CT-1 expression is unknown. The property of CT- 1 as a 
cardioprotective cytokine in stress conditions predicts upregulation during cardiac 
diseases which are characterized by an environment of hypoxia, inflammation and 
oxidative stress. It could be hypothesized that stress stimuli occurring during cardiac 
diseases regulate the expression of CT-1 which subsequently exerts its 
cardioprotective effect. A comparable microenvironment of hypoxia and elevated 
ROS generation may prevail in the heart of the early post-implantation embryo and 
may regulate CT-1 expression in the embryonic heart. Hypoxia and robust 
endogenous ROS production have been previously shown to occur in differentiating 
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ES cells and may represent one key stimulus for regulation of CT-1 expression as 
well as induction of the cardiomyogenic cell lineage [Sauer et al, 2000].  
 
FIG. 10 Schematic representation of signal pathways involved in CT-1 signalling. There exists evidence for the 
involvement of JAK, Stat1 / 3, MAPK and there is possibility of cross talk [Wollert, 1997] 
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1.4 AIM AND OBJECTIVES 
 
The current study was performed to evaluate the impact of the stress factors hypoxia 
and ROS on the signalling cascades resulting in CT-1 expression. Since 
differentiating ES cells into embryoid bodies mimic cardiomyogenic differentiation 
[Desbaillets et al, 2000; Itskovitz-Eldor et al, 2000; Kehat et al, 2003], and knowing 
that vascularised embryoid bodies are well oxygenated [Gassmann et al, 1996], we 
made use of this cell culture model. 
ES cell-derived embryoid bodies endogenously generate ROS – and express CT-1 
as well as the oxygen sensing element HIF-1α. The aim of this project was to find out 
whether: 
(i) CT-1 expression is regulated by ROS  
(ii) HIF-1α is involved in ROS dependent CT-1 expression 
 
In order to do this the following objectives were drawn; 
 
• Evaluation of the effect of exogenous ROS and hypoxia induced ROS 
generation on the expression of CT-1 and HIF-1α 
 
• Analysis of the site of ROS generation by analysing the expression of 
NADPH-oxidase 
 
• Analysis of the involvement of MAPKs in ROS dependent expression of 
CT-1 and HIF-1α 
 
• Analysis of the involvement of the JAK/STAT pathway in ROS induced 
CT-1 and HIF-1α up-regulation 
 
• Analysis of cellular localisation of CT-1 after stimulation of cells with 
exogenous ROS and chemical hypoxia. 
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2 MATERIALS AND METHODS 
 
2.1.1 MEDIUM AND CHEMICALS 
 
MEDIUM AND CHEMICALS 
Name Catalogue-Number Supplier 
β-Mercaptoethanol M7522 Sigma 
17β-Estradiol E4389 Sigma 
2´7´-dichlorodihydro-fluorescein diacetate (H2DCFDA) D-399 Molecular Probes 
2-Amino-methyl-pyridine 164575 Calbiochem 
2-Methoxyestradiol S-540 Biomol 
AEBSF Hydrochloride 101500 Calbiochem 
AG 18 658395 Calbiochem 
AG 490 658401 Calbiochem 
Apocynin 178385 Calbiochem 
IMDM F0465 Biochrom 
Collagenase B 1088807 Roche 
Detergent 7X 34205.01 Serva 
Diphenyleniodonium chloride D2926 Sigma 
DMEM high glucose D5671 Sigma 
DMSO 317275 Calbiochem 
DNAse I 18068-015 Invitrogen 
dNTP's 18427-013 Invitrogen 
Dulbecco´s PBS (1x) w/o Ca&Mg H15-002 PAA 
Ebselen E3520 Sigma 
ESGRO (LIF) ESG1106 Chemicon 
FCS F7524 Sigma 
Glycerol 49781 Sigma 
JNK Inhibitor  420119 Calbiochem 
JumpStart ReadyMix P-0982 Sigma 
KH2PO4  3094.2 Roth 
L-Glutamin 200mM (100x) M11-004 PAA 
Ly 294002 440202 Calbiochem 
MEK Inhibitor UO 126 V112A Promega 
MEM (50x) aminoacids K0363 Biochrom 
Menadion 2-methyl-1,4-naphtochinon 98% M5740-5 Sigma 
Mitomycin C M4287 Sigma 
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MMLV RT  Biorad 
Monothioglycerol M6145 Sigma 
N-(2-mercaptopropionyl)glycine M6635 Sigma 
N-acetyl-L-cysteine cell culture tested A9165 Sigma 
NaCl  3957.1 Roth 
NaH2PO4x2H2O 4984.2 Roth 
NEA (100x) K0293 Biochrom 
Penicillin/Streptomycin P11-010 PAA 
Primer  Invitrogen 
Random hexamer primer 48190-011  Invitrogen 
RNAlater-ICE 25ml 2833AE #7030 Ambion 
SB 202190 559388 Calbiochem 
SB 203580 Alx-270-179-M001 Alexis 
Sigmacote SL-2 Sigma 
SKF 86002 567305 Calbiochem 
Sodiumpyruvat (100mM) L0473 Biochrom 
Sterillium pharmacy  
Superscript II RTase 18064-014  Invitrogen 
Sytox Green Nucleic Acid Stain 5mM solution in DMSO S7020 Invitrogen 
Thymochinon 27.4666-6 Sigma 
Tosyl-l-phenylalanin-chloromethyl ketone T-4376 Sigma 
Triton X-100 8787 Sigma 
Trizol reagent  15596-018 Invitrogen 
Trolox 238813 Aldrich 
Trypsin /EDTA  25300-062 Invitrogen 
Water for  molecularbiology, DEPC-treated, steril A2864.0500 AppliChem 
Wortmannin 681675 Calbiochem 
TABLE 3 List of Reagents and Media Used 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
  29
2.1.2 ANTIBODIES 
 
ANTIBODIES 
Name Cataloge-Number Supplier 
cardiotrophin 1 (recombinant mouse) 438-010CF R&D Systems 
CT1 anti-mouse monoclonal (IgG) MAB438 R&D Systems 
Cy 2 goat anti-mouse (IgG + IgM (H +L)) 115-225-044 Dianova 
Cy 2 mouse anti-rat (IgG (H +L)) 212-225-082 Dianova 
Cy 3 donkey anti-goat (IgG (H +L)) 705-166-147 Dianova 
Cy 3 rabbit anti-rat (IgG, F(ab’)2 fragment) 312-165-047 Dianova 
Cy 5 goat anti-rabbit (IgG (H +L)) 111-175-144 Dianova 
Cy 5 mouse anti-goat (IgG (H +L)) 205-175-108 Dianova 
Cy 5 rabbit anti-rat (IgG, Fcg-fragment) AP164S Chemicon 
Cy 5 sheep anti mouse (IgG, F(ab’)2 fragment) 515-175-072 Dianova 
FITC anti-guinea-pig (IgG, Fab-specific) F7762 Sigma 
FITC goat anti-mouse (IgG) F8771 Sigma 
FITC sheep anti-rabbit (IgG) F7512 Sigma 
gp130 (IgG)                                                    --goat AF468 R&D Systems 
gp91-phox (C-15) (IgG)                                  --goat sc-5827 santa cruz 
HIF 1-α                                                           --mouse 
ABR-MA1-516-
R100 Alexis 
JAK2 (C-20) (IgG)                                          --rabbit sc-294 Santa Cruz 
MOX 1 (M-15) (IgG)                                       --goat sc-5819 Santa Cruz 
NOX 4 (M-15) (IgG)                                        --goat sc-21860 Santa Cruz 
p-gp130 (Ser 782) (IgG)                                 --goat sc-12978 santa cruz 
p-JAK2 (IgG)                                                  --goat sc-21870 santa cruz 
p22-phox(C-17) (IgG)                                    --goat sc-11712 santa cruz 
p67-phox (H-300) (IgG)                                 --goat sc-15342 santa cruz 
PI3-Kinase P85                                              --rabbit 4292 Cell Signaling 
phospho p38 MAP Kinase                              --rabbit 9211S Cell Signaling 
phosphop44/42 MAPKinase (Thr202/Tyr204)--rabbit 9101S Cell Signaling 
phospho SAPK/JNK (Thr183/Tyr185)             --rabbit 9251S Cell Signaling 
Phospho STAT3 (Ser727) (6E4) 9136 L Cell Signaling 
TABLE 4 List of Primary and Secondary Antibodies 
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2.1.3 MEDIA, BUFFERS AND SOLUTIONS 
 
10x PBS  
 
 
 
 
 
1x PBS 
4 g  KCl (26,82 mM) 
4 g  KH2PO4 (14,70 mM) 
160 g NaCl (1,37M) 
23 g Na2HPO4 * H2O (64,61 mM) 
dissolved in 2L H2O, set pH to 7,4 with HCl 
 
    10 x PBS 100 ml 
+   Water     900 ml 
0,01%PBST 
 
   1 x PBS   999 ml 
+ Triton    100 µl 
0,1%PBST   1 x PBS                   999 ml 
 + Triton  X-100           1 ml 
Blocking solution (10% FCS in 0,01% PBST) 5 ml FCS 
      + 45 ml 0,01% PBST 
Medium for feeder layer cultivation 
--IMDM with 10 % FCS 
 
- 500 ml IMDM-MEDIUM  
- 1,5 ml Penicillin / Streptomycin (100x) 
- 3,5 ml β-Mercaptoethanol (10 µM) 
- 6,25 ml L-Glutamine (100x) 
- 6,25 ml NEA (100x) 
- 6,25 ml MEM-Aminoacids (100x) 
- 6,25 ml Na- Pyruvat (100x) 
- 59 ml Heat-inactivated FCS  
Medium for embryoid body (EB) cultivation, 
Differentiation medium 
-- IMDM with 20 % FCS 
 
- 500 ml IMDM-MEDIUM  
- 2,5 ml Penicillin / Streptomycin (100x) 
- 3,5 ml β-Mercaptoethanol (10 µM) 
- 6,25 ml L-Glutamine (100x) 
- 6,25 ml NEA (100x) 
- 6,25 ml MEM-Aminoacids (100x) 
- 6,25 ml Na- Pyruvat (100x) 
- 132,5 ml Heat-inactivated FCS 
ES maintenance medium        49 ml IMDM with 10 % FCS 
+       1 ml LIF solution (1000U/ ml) 
TABLE 5 Composition of Cell Culture Media and Buffers 
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2.2 EMBRYONIC STEM CELL CULTURE  
 
Mouse ES-cells have been established as permanent lines of undifferentiated 
pluripotent cells as early as 1981 [Evans and Kaufman, 1981; Martin, 1981]. These 
cells are generally isolated from the inner cell mass of the preimplantation blastocyst. 
They can be maintained in a pluripotent state for indefinite periods of time in the 
presence of the leukemia inhibitory factor (LIF) or in coculture with mouse embryonic 
fibroblasts (MEFs). When cultured in the absence of LIF, ES cells differentiate 
spontaneously, forming three-dimensional (3D) aggregates called EBs. By cultivation 
in vitro as EBs, ES cells differentiate into derivatives of all 3 primary germ layers 
(ectoderm, mesoderm, and endoderm). The EB system is an extremely valuable tool 
for the investigation of embryonic development in vitro.  
 
Three mouse cell lines were used during this project: HIF-1α -/-, HIF-1α +/+, and CCE 
mouse ES cell lines. The HIF-1α -/- and HIF-1α +/+ cell lines were kindly donated by 
Max Gassmann Department of Veterinary Physiology, Zurich Switzerland. The CCE 
S103 line is a mouse ES cell line derived from 129/Sv mouse strain. It was made by 
the separate efforts of both Dr. Robertson E and Dr. Keller G [Robertson et al, 1986; 
Keller et al, 1993] 
 
The cells were cultured on inactivated feeder layers. Feeder layer cells are LIF 
producing cells from mouse fibroblasts, LIF hinders the stem cells from differentiating 
spontaneously. The ES cell maintenance medium (Iscoves medium) was 
supplemented with LIF in order to strengthen this effect. Medium change was 
performed every day.  
 
All cell-handling procedures, unless otherwise noted, were performed in a sterile 
laminar flow hood to prevent contamination. 
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2.2.1 CULTURE AND MAINTENANCE OF MOUSE FIBROBLASTS 
(FEEDER LAYER CELLS) 
 
The feeder layer cells seeded at a density of 9 x 104 were grown in 10% FCS IMDM 
to about 80% confluence (normally attained after 2-days) at 37°C and 5% CO2. The 
proliferation of the feeder layer cells was stopped by treating with mitomycin C. 
Mitomycin C is an antibiotic produced from Streptomyces caespitosus. It is an 
alkylating agent with anti-neoplastic properties. While mitomycin C is not cell cycle 
specific, it is most active in the late G1 and early S phase of the cell cycle. It acts by 
suppressing the synthesis of nucleic acids. In cell culture, mitomycin C mitotically 
arrests cells. 
 
• Inactivation of feeder layer cells 
- The cells were washed once with 1x PBS 
- 3 ml of mitomycin C dissolved in IMDM to an end concentration of 
10 µg/ ml was then given onto the cells and incubated for 3h at 
37°C, 5% CO2 
- The cells were washed 3x with 10% FCS IMDM  
- Medium change was performed every 2 days. Inactivated Feeder 
cells should be stored not more than a week 
The ES cells can then be seeded on to the feeder layer cells using the ES 
maintenance medium. 
 
2.2.2 ES CELL CULTURE AND SPINNER-CULTURE TECHNIQUE FOR 
CULTIVATION OF EMBRYOID BODIES 
 
The ES cell lines were thawed at 37°C within a waterbath after storage in liquid 
nitrogen (-196°C) and centrifuged with the Heraeus Labofuge 300 at 65 g for 5 min in 
5 ml Iscove’s medium. The cell pellet was then re-suspended in 2 ml ES-cell medium 
from which 200 µl was transferred into a 60 x 20 mm cell culture plate containing 
mitotically inactivated feeder layers preincubated with 5 ml ES maintenance medium 
(see TABLE 5). The cells were cultured at 37°C, 5% CO2 with 95% relative humidity, 
and passaged every 2-3 days.  
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At day 0 of differentiation adherent cells were dissociated using 0.2% trypsin and 
0.05% EDTA in PBS and seeded at a density of 1x107 cells / ml in 250  ml siliconised 
spinner flasks (in order to prevent the cells from adhering to the spinner flask walls) 
[Integra] containing 125 ml differentiation medium (see TABLE 5). After 24 h 125 ml 
medium was added to give a final volume of 250 ml. The cells in the spinner flask are 
held in steady movement at 37°C on a magnetic stirrer [Integra] with 20 rpm and 
change of direction after four rotations. About 150 ml cell culture medium was 
exchanged every day from the spinner flask. In the spinner flasks the cells aggregate 
to form EBs and start differentiating spontaneously due to the absence of LIF (see 
FIG. 11). The incubator condition was the same as mentioned above. 
 
For endogenous gene expression analysis during the course of differentiation, 
aliquotes of EBs were removed from day 2 to day 10 and analysed using 
immunohistochemistry for protein- or using real-time PCR for mRNA expression. For 
other experiments 4-day-old EBs were treated for 24h in medium supplemented with 
various test substances under the same condition as mentioned above. 
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Confluent feeders ES cells seeded on mitomycin
inactivated feeders –1 day old
Confluent ES cells---
3 days old
ES cells in spinner flask  
for building of EBs and 
induction of differentiation
EBs after 24h 
aggregation
Single EB at day 5
 
FIG. 11 Culture and Differention of Feeder Cells Dependent ES Cells 
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2.3 TREATMENT OF EBs WITH VARIOUS SUBSTANCES 
 
STIMULANTS: 
 
In order to study the effect of changes in redox milieu on gene expression during the 
differentiation of ES cells the substances listed in TABLE 6 were used. 4-day-old EBs 
were treated for 24h or for times as indicated and analysed either by 
immunohistochemistry or real time PCR. 
 
SUBSTANCE CONCENTRATION 
Cobalt chloride 50 µM 
Hydrogen peroxide 10 µM 
Menadione 20 µM 
Physiological hypoxia (N2) 100 mbar 95% N2, 1% O2 
TABLE 6 List and Concentration of Substances Used as Pro-Oxidants 
  
ANTIOXIDANTS: 
 
Listed in TABLE 7 are the substances and their concentrations that were used to 
study the effect of ROS scavenging on the expression of CT-1 and HIF-1α. 
 
SUBSTANCE CONCENTRATION 
Trolox 20 µM 
N-(2-mercaptopropionyl)glycine (NMPG) 20 µM 
TABLE 7 Concentration of Anti-Oxidants Used 
 
NADPH OXIDASE INHIBITORS: In order to find out whether NADPH-oxidase is 
involved in the redox-dependent regulation of CT-1 and HIF-1α expression, NADPH 
oxidase inhibitors were used as shown in TABLE 8 below. 
 
SUBSTANCE CONCENTRATION 
Apocynin 10 µM 
Diphenyleniodonium chloride (DPI) 10 µM 
TABLE 8 Concentration of NADPH-Oxidase Inhibitors Used 
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INHIBITORS: 
 
In order to analyse the possible signal transduction pathways that are involved in 
redox-dependent regulation of CT-1 and HIF-1α, inhibitors were used as indicated 
below (see TABLE 9). 
 
SUBSTANCE SUBSTRATE CONCENTRATION 
2-Methoxyestradiol HIF-1α 3 µM 
AG 490 JAK2 50 µM 
LY294002 PI-3K 20 µM 
SKF 86002 p38 MAPK 10 µM 
SP 600125 JNK 10 µM 
U0126 ERK 1/2 10 µM 
TABLE 9 Concentration and Substrate of Inhibitors Used 
 
2.4 FIXATION AND IMMUNOFLUORESCENCE STUDIES 
Depending on the target protein, the EBs were fixed either by incubating for 20 min at 
-20°C in 100% methanol or by incubating for 1h on ice in ice-cold 4% 
paraformaldehyde. The EBs were then washed 2x with 1x PBS to remove the excess 
fixative. In order to reduce unspecific binding of the antibodies, the EBs were 
incubated in blocking buffer (either 10% FCS in 0.01% PBST or 10% skimmed milk in 
0.01% PBST) for 1h at RT. The primary antibodies were diluted in blocking solution 
as shown in TABLE 10 below, and were incubated either for 1h at RT or overnight at 
4°C. The EBs were then washed 5x with 0,1x PBST to remove the unbound 
antibodies. The secondary antibodies were also diluted in blocking solution as shown 
in TABLE 11 below; the seconary antibody incubation lasted usually for 1h at RT. 
After that the EBs were washed 5x with 0,1x PBST and stored in 0.01% PBST. The 
protein fluorescence analysis was performed using the Zeiss LSM 510 confocal laser 
scanning microscope (CLSM). 
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2.4.1 PRIMARY ANTIBODY STAINING 
 PRODUCED IN FIXATION Dil. 
HIF 1-α                                         mouse Methanol 20min -20°C 1:100 
CT-1                                            rat „ 1:100 
gp130                                          goat „ 1:100 
p-gp130 (Ser 782)                           goat „ 1:100 
MOX 1 (M-15)                              goat Methanol 20min -20°C 1:50 
NOX 4 (M-15)                                goat „ 1:50 
gp91-phox (C-15)                          goat „ 1:50 
P47-phox (H-300)                            goat „ 1:50 
p22-phox(C-17)                               goat „ 1:50 
p67-phox (H-300)                            rabbit „ 1:50 
p-STAT3 rabbit „ 1:50 
PI3-Kinase P85                              rabbit 4% PFA 1h on ice 1:50 
phospho p38 MAP Kinase             rabbit „ 1:50 
phosphop44/42 MAPKinase (Thr202/Tyr204) rabbit „ 1:50 
phospho SAPK/JNK (Thr183/Tyr185) rabbit „ 1:50 
TABLE 10 Fixation Method and Dilution of Primary Antibodies Used 
 
SECONDARY ANTIBODIES 
 
 
 
 
 
 
 
 
 
 
TABLE 11 Dilution of Secondary Antibodies Used 
 
 
 
 
SECONDARY ANTIBODIES DILUTION 
Cy 2 goat anti-mouse 1:200 
Cy 2 mouse anti-rat 1:200 
Cy 3 donkey anti-goat 1:200 
Cy 3 rabbit anti-rat 1:200 
Cy 5 goat anti-rabbit 1:200 
Cy 5 mouse anti-goat 1:200 
Cy 5 rabbit anti-rat 1:200 
Cy 5 sheep anti mouse IgG 1:200 
FITC anti-guinea-pig IgG 1:300 
FITC goat anti-mouse  1:300 
FITC sheep anti-rabbit IgG 1:300 
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2.4.2 VISUALISATION AND DATA ANALYSIS: CONFOCAL LASER 
SCANNING MICROSCOPY (CLSM) 
 
CLSM is a conventional microscope which is equipped with a laser light source, the 
laser scanning head, and an automatic focusing stage, connected to a monitor and 
PC. Operation is possible in two modes: in reflected light or in fluorescence mode. 
The basic principle of a confocal microscope is that light from a laser is focused onto 
a pinhole. The pinhole is imaged onto the object by an objective lens. Reflected light 
and/or fluorescence from the object are imaged by the same objective lens onto a 
detection pinhole via a beamsplitter. A photomultiplier-detector records the light 
transmitted through the pinhole. In this way, light rays generated from outside the 
focused region are effectively suppressed by the detection pinhole (optical 
sectioning-effect). An image of the object is obtained by scanning the light beam in 
x/y-directions, in raster-like manner. Finally, a 3D-image is obtained by scanning the 
object in z-direction (along the optical axis) and stacking the images obtained for 
each z-value. Using these arrangement images of objects with a resolution up to 1.4 
x higher than in a non-confocal system can be obtained. Confocal microscopes use 
specific wavelengths of light to excite fluorescent molecules within a sample. Our 
Zeiss 510 uses the following lasers: 458/488nm Argon, 543nm HeNe (Helium/Neon), 
and a 633nm HeNe. Following excitation of fluorescent molecules with certain 
wavelengths of light, those molecules then relax. Upon this relaxation, the molecules 
emit light at specific wavelengths. This emission is the signal we detect when doing 
confocal microscopy. In TABLE 12 below are the spectral data of the fluorochromes 
in this work. 
Fluorochrome Spectral data [nm] 
 
Absorption Emission 
Cy2 489 506 
Cy3 514 566 
Cy5 649 666 
Dichlorodihydrofluorescein Diacetate 
(H2DCFDA) 
505 535 
FITC 490, 494 520, 525 
TABLE 12 Spectral Data of Fluorochromes used. 
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2.5 POLYMERASE CHAIN REACTION (PCR) 
 
The coupling of reverse transcription (RT) of mRNA with PCR amplification of the 
resulting cDNA (RT-PCR) was initially described by Powell and colleagues in 1987. 
Subsequently, RT-PCR has been widely used in research laboratories as a rapid and 
sensitive technique for the detection, quantification of specific mRNAs. RT-PCR 
(reverse transcription-polymerase chain reaction) is the most sensitive technique for 
mRNA detection and quantitation currently available. Compared to the two other 
commonly used techniques for quantifying mRNA levels, Northern blot analysis and 
RNase protection assay, RT-PCR can be used to quantify mRNA levels from much 
smaller samples.  
Real-time is a method of simultaneous DNA quantification and amplification. DNA is 
specifically amplified by polymerase chain reaction (PCR). After each round of 
amplification, the DNA is quantified. Common methods of quantification include the 
use of fluorescent dyes that intercalate with double-strand DNA and modified DNA 
oligonucleotides (called probes) that fluoresence when hybridized with a 
complementary DNA. Frequently, real-time PCR is combined with reverse 
transcription-polymerase chain reaction (RT-PCR) to quantify low abundance 
messenger RNA, enabling a researcher to quantify relative gene expression at a 
particular time, or in a particular cell or tissue type. The combined technique is often 
called quantitative RT-PCR. 
2.5.1 RNA ISOLATION AND DNase DIGESTION 
 
RNA EXTRACTION USING TRIZOL PROTOCOL 
EBs were transferred into 1.5 ml Eppendorf tubes, washed once with 1x PBS and 
centrifuged (Heraeus Biofuge 15R) for 1min at 11000 g at RT. 300 µl TRIzol reagent 
(Invitrogen) was then added. Homogenisation of EBs was achieved by pipetting for at 
least 10 times and vortexing. After 5min incubation at RT the homogenate was 
centrifuged at 11000 g for 20 min at 4°C in pre-cooled centrifuge. The supernatant 
was removed to a fresh Eppendorf tube and 300 µl of chloroform was added and 
mixed by vortexing before incubation at RT for 5 min. After 10 min centrifugation at 
11000 g, at 4°C, the aqueous phase (~500 µl) was transferred to a fresh Eppendorf 
tube. RNA was precipitated with 0.5 ml of isopropanol for 20 min at – 20°C. The 
precipitate was pelleted by centrifugation at 11000 g for 20 min at 4°C. The 
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supernatant was removed and the pellet was washed twice with 1 ml 70% EtOH by 
centrifugation at 4500 g for 5 min at 4°C, air dried, and re-suspended in ca 33 µl 
RNase-free water. In order to eliminate DNA contamination, DNase digestion was 
performed with Dnase I RNase-free. DNase I is a nonspecific endonuclease that 
degrades double-and single-stranded DNA and chromatin. It functions by hydrolyzing 
phosphodiester linkages, producing mono and oligonucleotides with a 5'-phosphate 
and a 3'-hydroxyl group. 
 
DNase DIGESTION 
 
To remove genomic DNA contamination, the RNA solution was treated with 10 U of 
RNase-free DNase I in the presence of 50 mM Tris pH 7.5, 1 mM MgCl2, 5 mM DTT, 
and 1 U/µl RNasin at 37 °C for 1h. Water was added up to 250 µl, and the RNA was 
purified by extraction with phenol-chloroform (3:1) and chloroform. The RNA was 
precipitated from the aqueous phase by adding sodium acetate up to 0.3 M and 2.5 
vol of 100 % ethanol. The RNA pellet was redissolved in 20 µl of RNase-free water 
and the RNA concentration was measured with a spectrophotometer.  
RNA concentration was estimated by measuring A260 in a spectrophotometer 
(Eppendorf) and applying the formula: [RNA] = A260 x D x 40 µg/µL, where D is the 
RNA dilution factor. RNA quality was judged from A260/280 (ratio 1.8-2.0, indicates 
low protein contamination) and A260/230 (ratio ≥ 2.0, indicating low polysaccharide 
contamination). 
2.5.2 cDNA SYNTHESIS 
Each RNA sample was reverse transcribed using oligo-dT primer. For the reactions, 
2 µg of DNase-treated RNA was filled with water to volume of 10 µl. The RNA 
solution was incubated at 60°C for 15 min to denature the RNA and quick chilled on 
ice for 1 min, microcentrifuged at 11000 g for 10 sec. A mix containing 4 µl of 5x 
Reverse Transcription buffer, 1 µl of 0.1 M DTT, 2 µl of 100 µM 4dNTP mix, and 2 µl 
of 10 µM oligo-dT primer and 1 µl of 200 U/µl MMLV reverse transcriptase was 
added into each tube, giving a final reaction volume of 20 µl. The reactions were 
incubated at 37°C for 60min. To inactivate the reverse transcriptase, the samples 
were incubated at 95°C for 5 min, then microcentrifuged at 10000 g for 10sec, and 
placed on ice or stored at –20°C for later PCR amplification. 
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2.5.3 QUANTITATIVE PCR 
The real-time PCR system is based on the detection and quantification of a 
fluorescent reporter (Lee, 1993; Livak, 1995). This signal increases in direct 
proportion to the amount of PCR product in a reaction. By recording the amount of 
fluorescence emission at each cycle, it is possible to monitor the PCR reaction during 
exponential phase where the first significant increase in the amount of PCR product 
correlates to the initial amount of target template. 
 
Real-time PCR requires an instrumentation platform that consists of a thermal cycler, 
a computer, optics for fluorescence excitation and emission collection, and data 
acquisition and analysis software. 
 
Currently four different chemistries, TaqMan® (Applied Biosystems, Foster City, CA, 
USA), Molecular Beacons, Scorpions® and SYBR® Green (Molecular Probes), are 
available for real-time PCR. All of these chemistries allow detection of PCR products 
via the generation of a fluorescent signal. TaqMan probes, Molecular Beacons and 
Scorpions depend on Förster Resonance Energy Transfer (FRET) to generate the 
fluorescence signal via the coupling of a fluorogenic dye molecule and a quencher 
moeity to the same or different oligonucleotide substrates. SYBR Green was used 
during this work. SYBR Green is a fluorogenic dye that exhibits little fluorescence 
when in solution, but emits a strong fluorescent signal upon binding to double-
stranded DNA. 
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2.5.3.1 DATA ANALYSIS 
 
Two strategies are commonly employed to quantify the results obtained by real-time 
RT-PCR; the standard curve method and the comparative threshold method.  The 
comparative threshold method was used in this project. This involves comparing the 
Ct (cycle number at which a PCR reaction enters its exponential phase) values of the 
samples of interest with a control or calibrator such as a non-treated sample or RNA 
from normal tissue. The Ct values of both the calibrator and the samples of interest 
are normalized to an appropriate endogenous housekeeping gene.  
The comparative Ct method is also known as the 2–[delta] [delta]Ct method, where  
 
[delta][delta]Ct=[delta]Ct,sample-[delta]Ct,reference 
 
Here, [delta]CT,sample is the Ct value for any sample normalized to the endogenous 
housekeeping gene and [delta]Ct, reference is the Ct value for the calibrator also 
normalized to the endogenous housekeeping gene. For the [delta][delta]Ct 
calculation to be valid, the amplification efficiencies of the target and the endogenous 
reference must be approximately equal. This can be established by looking at how 
[delta]Ct varies with template dilution. If the plot of cDNA dilution versus delta Ct is 
close to zero, it implies that the efficiences of the target and housekeeping genes are 
very similar. 
 
2.5.3.2 REACTION CONDITIONS 
 
PCR amplification was carried out in 20 µl reaction mixtures per tube containing 10 µl 
of SYBR Green PCR Master Mix, 10 pM of each primer, and 3 µl of cDNA using the 
ICycler Optical Module (Biorad). PCR conditions were set as follows: 15 min at 95°C 
to activate the polymerase followed by 45 cycles consisting of denaturation at 95°C 
for 30sec and annealing 60-64°C for 30 sec (see primer sequences and annealing 
temperatures in TABLE 13 below) and elongation at 72°C for 30 sec. The data were 
analysed with the Bio-Rad ICycler iQ software. Signals were regarded positive if the 
fluorescence intensity (increase of fluorescence ∆Rn) exceeded 10 times the 
standard deviation of the baseline fluorescence (threshold cycle [CT]). CT values of 
45 were regarded as negative. The threshold cycle or CT value is the cycle at which 
a statistically significant increase in ∆Rn is first detected. 
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  SEQUENCES Temperature 
BACT forward GATGACCCAGATCATGTTTGAG 60°C 
BACT reverse CCATCACAATGCCTGTGGTA 60°C 
GAPDH forward TCGTCCGGTAGACAAAATGG 64°C 
GAPDH reverse GAGGTCAATGGGGTCGT 64°C 
CT-1 forward GCGTCGCCTGAGAGTGAATAC 64°C 
CT-1 reverse GAACACACAGGACACAGATGGAG 64°C 
HIF1a forward TCACCAGACAGAGCAGGAAA 60°C 
HIF1a reverse CTTGAAAAAGGGAGCCATCA 60°C 
NOX 1 forward AATGCCCAGGATCGAGGT 60°C 
NOX 1 reverse GATGGAAGCAAAGGGAGTGA 60°C 
NOX 4 forward GATCACAGAAGGTCCCTAGCAG 64°C 
NOX 4 reverse GTTGAGGGCATTCACCAAGT 64°C 
TABLE 13  Lists of primers and their annealing temperatures 
HIF-1α and NOX 1 data were normalised against the β –actin (BACT) data and CT-1 
and NOX 4 data were normalised against the GAPDH data. 
 
2.6 ENZYMATIC DISSOCIATION OF EMBRYOID BODIES INTO 
SINGLE CELLS USING COLLAGENASE 
 
To obtain single cells and cardiomyocytes, EBs were removed from the spinner 
flasks on day 4 of differentiation and plated on petriperm plates. Three days after 
plating (i.e. day 7 of differentiation) a number of EBs displayed spontaneous 
contractions, indicating cardiomyocyte differentiation. On day 8 of differentiation, EBs 
with beating areas were cut out with a sterile microscalpel and collected in IC-buffer 
(see TABLE 14). The tissue was then incubated in enzyme medium (collagenase B 
(1 mg/ ml); 30 µM CaCl2) for 20 min at 37°C with gentle rotation on a shaker and then 
centrifuged (Eppendorf 5417C) at 665 g for 5 min. The supernatant was discarded 
and the pellet resuspended in Iscove’s medium. Isolated cells were plated on sterile 
coverslips and kept in the incubator for 96 h. The isolated cells were treated for 24 h 
and the cellular localisation of CT-1 in cardiomyocytes as well as non-cardiomyocyte 
was analysed. 
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 Molecular weight (g/Mol) mmol/l g/l 
NaCl 58,44 120 7 
KCl 74,56 5,4 0,4 
MgSO4  246,48 5 1,23 
Na-Pyruvat 0,1 5 50  ml 
Glucose 198,19 20 3,96 
Taurin 125,15 20 2,5 
HEPES 238,31 10 2,38 
→ adjusted to pH 6,9 with NaOH  
TABLE 14 Cardiomyocyte Isolation Buffer (IC-Buffer) 
 
2.7 MEASUREMENT OF REACTIVE OXYGEN SPECIES 
 
ROS generation in EBs was assessed using the probe 2,7-dichlorofluorescin (DCF). 
The membrane-permeable diacetate form of the dye (H2DCF-DA) was added to the 
EBs that were incubated in serum-free medium at a final concentration of 20 µM. 
H2DCF-DA is a low molecular-weight non-fluorescent and non-polar compound that 
enters cells freely. Within the cells, esterases cleave the acetate groups on the 
H2DCF-DA, resulting into a polar and non-fluorescent DCFH thus trapping the 
reduced probe (DCFH) intracellularly. ROS in the cells oxidize DCFH, yielding the 
fluorescent product DCF. After 20 min of incubation, DCF fluorescence was 
measured using the 488-nm band of the argon ion laser of the confocal setup. The 
intensity of green fluorescence of DCF is an indicator of the levels ROS production. 
 
2.8 STATISTICS 
 
Results are expressed as means ± SD, were n represents the number of 
experimental replicates (n≥3). Statistical significance was assessed by Student’s t-
test and ANOVA. P< 0.05 was considered significant. 
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3 RESULTS 
 
3.1 CT-1 AND GP130 EXPRESSION IN DIFFERENTIATING CCE ES 
CELLS 
 
Sauer et al. 2004 showed that treatment of ES cell-derived embryoid bodies with CT-
1 results in stimulation of cardiomyogenesis, and that CT-1 is endogenously 
expressed in embryoid bodies. To correlate CT-1 with the time course of embryoid 
body differentiation and expression of the transducing receptor (gp130), protein 
levels of CT-1 and gp130 were monitored. Expression of CT-1 (n = 6) and gp130 (n = 
4) followed a similar expression pattern until day 8 in culture and subsequent 
downregulation on day 10 and day 11 (FIG. 12A, B). Expression of CT-1 and gp130R 
culminated at 175 + 25 % and 188 + 6 %, respectively, on day 8 as compared to day 
2 (set to 100 %).  It has been previously shown by Hescheler et al. 2002 that 
cardiomyogenic differentiation of mouse ES cells occurs between day 6 and 8, i.e. 
during the time of maximal CT-1 and gp130 expression. 
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FIG. 12 Protein expression of CT-1 (A) and gp130 (B) during ES cell differentiation. Determination was 
performed within the three-dimensional tissue of embryoid bodies by semiquantitative immunohistochemistry. 
Note that cardiac cell differentiation occurs during day 6 and 8 of embryoid body cell culture. *P < 0.05, 
significantly different to day 1 and day 2 of cell culture in (A) and (B), respectively. 
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3.2 REGULATION OF CT-1 AND HIF-1α EXPRESSION BY  
VITAMIN E 
It was previously shown that differentiating embryoid bodies express HIF-1α  and 
robustly generate ROS that may be utilized as signalling molecules regulating CT-1 
expression [Bichet et al, 1999; Sauer et al, 2000]. To support this assumption 
embryoid bodies were treated with the free radical scavenger vitamin E (20 µM) from 
day 2 to day 8 (FIG. 13). Subsequently, CT-1 expression was assessed in untreated 
and vitamin E-treated embryoid bodies. Since CT-1 has been previously shown to be 
upregulated by hypoxic stress in cardiac myocytes [Hishinuma et al, 1999) the 
expression of HIF-1α was assessed in parallel to investigate possible correlation with 
CT-1 expression. It was apparent that vitamin E treatment downregulated CT-1 as 
well as HIF-1α expression in 8-day-old embryoid bodies (untreated control set to 100 
%), indicating regulation by ROS endogenously generated in differentiating ES cells 
(n = 4).  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
FIG. 13 Regulation of CT-1 and HIF-1α expression in embryoid bodies by endogenous ROS. Embryoid bodies 
were incubated from day 2 to day 8 of cell culture with 20 µM vitamin E. On day 8 protein expression of CT-1 
and HIF-1α was assessed by semiquantitative immunohistochemistry in whole mount embryoid bodies. The 
images show representative embryoid bodies labelled with antibodies either against CT-1 or HIF-1α  which 
remained untreated (a,c) or were treated with vitamin E (b,d). The bar represents 100 µm. *P < 0.05, 
significantly different to the untreated control. 
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3.3 REGULATION OF CT-1 AND HIF-1α EXPRESSION BY 
EXOGENOUS PRO-OXIDANTS 
 
The data above suggest regulation of CT-1 and HIF-1α by endogenous generation of 
ROS during differentiation. To validate these findings, 4-day-old embryoid bodies 
were treated with either the prooxidants menadione or H2O2 (FIG. 14A, B). Treatment 
of embryoid bodies with H2O2 in concentrations ranging from 1 nM to 100 µM 
resulted in dose-dependent increase of CT-1 protein expression (data not shown).  
Maximum effects were achieved at 10 µM H2O2 which increased CT-1 protein (FIG. 
14A) and mRNA expression (FIG. 14B) to 145 + 8% and 140 + 9%, respectively (n = 
3) (untreated control set to 100 %). Likewise, treatment with 10 µM (data not shown) 
and 20 µM menadione resulted in increased CT-1 expression with maximum values 
of 157 + 8 % and 175 + 7 % for CT-1 protein (n = 3) (FIG. 14A) and mRNA (n = 3) 
(FIG. 14B) expression, respectively, at 20 µM menadione concentration. Under the 
same experimental conditions increased protein as well as mRNA expression of HIF-
1α was observed. HIF-1α protein expression amounted to 140 + 8% and 184 + 9% 
(see FIG. 14A), and mRNA expression to 220 + 24% and 264 + 7% for H2O2 and 
menadione, respectively. 
 
3.4 UP-REGULATION OF CT-1 AND HIF-1α EXPRESSION BY 
HYPOXIA 
 
Regulation of CT-1 on the protein as well as mRNA level paralleled the regulation of 
HIF-1α. Consequently, it was hypothesized that hypoxia vice versa results in up-
regulation of CT-1. To address this assumption, 4-day-old embryoid bodies were 
exposed to either 24 h of physiological (1% O2) or chemical (50 µM CoCl2) hypoxia 
(FIG. 15A, B). Physiological (n = 3) as well as chemical hypoxia (n = 4) upregulated 
CT-1 protein expression to 191 + 18% and 157 + 13%, respectively, whereas 
increased levels of HIF-1α protein amounting to 192 + 20% (n = 3) and 183 + 16 % 
(n = 3) were observed upon physiological and chemical hypoxia, respectively (see 
FIG. 15A). A significant increase in CT-1 as well as HIF-1α mRNA expression 
amounting to 192 + 8 % (n = 3) and 279 + 24 % (n = 4), respectively, was only 
achieved with chemical hypoxia (FIG. 15B).  
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FIG. 14 Upregulation of CT-1 and HIF-1α protein (A) and mRNA (B) upon treatment with the prooxidants 
menadione (20 µM) and H2O2 (10 µM). Embryoid bodies were treated on day 4 with the respective substances 
and were examined 24 h thereafter. The images show representative embryoid bodies labelled with antibodies 
against CT-1 (left panel) and HIF-1α (right panel) which remained either untreated (a,d) or were treated with 
menadione (b,e) or H2O2 (c,f). The bar represents 200 µm. *P < 0.05, significantly different to the untreated 
control. 
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FIG. 15 Upregulation of CT-1 and HIF-1α protein (A) and mRNA (B) upon exposure to hypoxia. Embryoid 
bodies were treated on day 4 of cell culture with either physiological (1% O2) or chemical (CoCl2) hypoxia and 
were examined 24 h thereafter. The images show representative embryoid bodies labelled with antibodies against 
CT-1 (left panel) and HIF-1α (right panel) which remained either untreated (a,d) or were treated with 1% O2 
(b,e) or CoCl2 (50 µM) (c,f). The bar represents 200 µm. *P < 0.05, significantly different to the untreated 
control. 
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3.5 DIFFERENTIAL UP-REGULATION OF CT-1 AND HIF-1α 
EXPRESSION BY MENADIONE AND CHEMICAL HYPOXIA 
 
The above data shows that both ROS and hypoxia lead to the up-regulation of HIF-
1α as well as CT-1. In order to correlate these expression data and our hypothesis 
that HIF-1α might be involved in the redox dependent expression of CT-1, it was 
necessary to perform time course experiments to find out whether and/or these 
proteins are differentially expressed. Assessment of the time course of HIF-1α and 
CT-1 (FIG. 16B) expression upon treatment with either menadione (FIG. 16A) (n = 3) 
or CoCl2 (FIG. 16B) (n = 4) revealed that up-regulation occurred already after 2 h of 
incubation. Statistical significance was achieved at earlier time points for HIF-1α 
expression as compared to CT-1 expression, i.e. after 2 and 4 h in menadione and 
CoCl2 treated samples, respectively, suggesting that HIF-1α precedes CT-1 
expression. 
 
3.6 GENERATION OF ROS BY MENADIONE AND CHEMICAL 
HYPOXIA IN EMBRYOID BODIES 
 
Pro-oxidants as well as chemical hypoxia may increase intracellular ROS generation. 
When embryoid bodies were treated for 24 h with 20 µM menadione, a significant 
increase in ROS generation was observed which remained at an elevated level even 
24 h after placement into normal medium, but was not significantly different to the 
control after 4 h (FIG. 17A) (n = 4).  An increase in ROS generation was likewise 
achieved when embryoid bodies were treated for 24 h with CoCl2 (FIG. 17B) (n = 3), 
suggesting that indeed ROS may act as signalling molecules regulating the 
expression of CT-1 and HIF-1α following treatment with menadione and chemical 
hypoxia.  
 
 
 
 
 
 
 
RESULTS 
  52
re
la
tiv
e
 
pr
o
te
in
 
e
xp
re
ss
io
n
 
(%
)
80
100
120
140
160
180
200
HIF-1α 
CT-1 
time after treatment (h)
0 2 4 6 8 10 12 14 16 18 20 22 24
re
la
tiv
e
 
pr
o
te
in
 
e
xp
re
ss
io
n
 
(%
)
60
80
100
120
140
160
180
200
*
*
*
*
#
#
#
#
*
HIF-1α 
CT-1 
* *
#
A
B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 16 Time course of HIF-1α and CT-1 up-regulation upon treatment with either menadione (A) or CoCl2 (B). 
Protein expression was assessed 2, 4, 8, and 24 h after treatment. *,#P < 0.05, significantly different as compared 
to untreated samples. 
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FIG. 17 Generation of ROS following exposure to menadione (A) or chemical hypoxia (CoCl2 treatment) (B). In 
A, embryoid bodies were treated for 24 h with 20 µM menadione. Subsequently, the cell culture medium was 
exchanged with medium devoid of menadione, and ROS were monitored at different times after removal of 
menadione. B, ROS generation in the presence of either menadione (20 µM) or CoCl2 (50 µM). Determination 
was performed immediately after exposure. *P < 0.05, significantly different to the untreated control. 
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3.7 ATTENUATION OF MENADIONE- AND CHEMICAL HYPOXIA- 
INDUCED CT-1 UP-REGULATION BY FREE RADICAL 
SCAVENGERS 
The  hypothesis of involvement of ROS in the menadione and CoCl2 induced CT-1 
up-regulation mentioned above was further strengthened by experiments where CT-1 
expression following treatment with menadione (FIG. 18A) (n = 3) and CoCl2 (FIG. 
18B) (n = 4) was assessed in the presence of the free radical scavengers vitamin E 
(20 µM) and NMPG (20 µM) which resulted in significant down-regulation of CT-1 
expression, thus pointing towards regulation of CT-1 expression by intracellular ROS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 18 Inhibition of menadione- (A) and CoCl2-mediated (B) upregulation of CT-1 upon preincubation with 
either the free radical scavenger vitamin E (20 µM) or NMPG (20 µM). Embryoid bodies were treated at day 4 
of cell culture with either menadione (20 µM) or CoCl2 (50 µM) in the presence of free radical scavengers. 
Following 24 h CT-1 protein expression was determined by semiquantitative immunohistochemistry. *,#P < 
0.05, significantly different as indicated. 
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3.8 UP-REGULATION OF NADPH-OXIDASE IN EMBRYOID BODIES 
BY MENADIONE AND HYPOXIA 
 
Pro-oxidants may regulate the expression of ROS generating NADPH-oxidase 
thereby providing a feed-forward loop of increased ROS generation even in the 
absence of external pro-oxidants. To evaluate this notion, we determined expression 
of NADPH-oxidase subunits. Pre-incubation for 24 h with either menadione (20 µM) 
or CoCl2 (50 µM) significantly increased protein expression of p22-phox, p47-phox, 
p67-phox, Nox-1 and Nox-4 (FIG. 19A) (n = 4) as well as mRNA expression of Nox-1 
and Nox-4 (FIG. 19B) (n = 5), suggesting regulation of CT-1 expression by NADPH-
oxidase-derived ROS. Furthermore, treatment with physiological hypoxia (1% O2) 
significantly increased protein expression of p22-phox, p47-phox and Nox-4 (FIG. 
19C). 
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FIG. 19 Upregulation of NADPH-oxidase subunits upon incubation of embryoid bodies with menadione and 
CoCl2. A, increase in protein expression of the NADPH-oxidase subunits p22-phox, p47-phox, p67-phox, Nox-1 
and Nox-4 which were determined 24 h after treatment of 4-day-old embryoid bodies by semiquantitative 
immunohistochemistry. B, mRNA expression of Nox-1 and Nox-4 upon either menadione (20 µM) or CoCl2 (50 
µM) treatment. C, increase in protein expression of the NADPH-oxidase subunits p22-phox, p47-phox, Nox-4 
upon treatment with physiological hypoxia (1% O2). *P < 0.05, significantly different to the untreated control. 
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3.9 ATTENUATION OF MENADIONE- AND CHEMICAL HYPOXIA- 
INDUCED CT-1 UP-REGULATION BY NADPH-OXIDASE 
INHIBITORS 
 
The involvement of NADPH-oxidase in the regulation of CT-1 expression was further 
substantiated by incubating embryoid bodies with either menadione (20 µM) or CoCl2 
(50 µM) in the presence of the NADPH-oxidase inhibitors DPI (10 µM) (n = 3) or 
apocynin (10 µM) (n = 3) (FIG. 20). This treatment significantly inhibited the increase 
in CT-1 expression following treatment with either menadione or CoCl2, thus 
indicating that NADPH-oxidase-derived ROS are involved in up-regulation of CT-1 by 
pro-oxidants and hypoxia.  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
FIG. 20 Inhibition of menadione- and CoCl2-mediated upregulation of CT-1 upon preincubation with the 
NADPH-oxidase inhibitors DPI (10 µM) or apocynin (10 µM). Embryoid bodies were treated at day 4 of cell 
culture with either menadione (20 µM) or CoCl2 (50 µM) in the presence of either DPI or apocynin. Following 
24 h CT-1 protein expression was determined by semiquantitative immunohistochemistry. The images show 
representative embryoid bodies: a, untreated; b, menadione-treated; c, CoCl2-treated; d, DPI-treated; e, DPI- + 
menadione-treated; f, DPI- + CoCl2-treated; g, apocynin-treated; h, apocynin- + menadione-treated; i, apocynin- 
+ CoCl2-treated. The bar represents 100 µm. *,#P < 0.05, significantly different as indicated. 
b c d g h i e f a 
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3.10  SIGNALLING CASCADES INVOLVED IN THE UP-REGULATION 
OF CT-1 IN EMBRYOID BODIES BY MENADIONE AND 
CHEMICAL HYPOXIA 
 
Upon binding of CT-1 to a LIFR-ß: gp130 heterodimer a complex signalling cascade 
is activated which involves the MAPK members ERK1,2, JNK and p38 as well as PI3-
kinase and the JAK/STAT pathway [Sauer et al, 2003].  
 
The data in section 3.2 to section 3.7 above shows clearly that pro-oxidants as well 
as hypoxia influenced the regulation of both CT-1 and HIF-1α gene expressions 
using a mechanism that involves ROS. Furthermore, the results in section 3.9 
implicated the involvement of NADPH-oxidase in the ROS dependent regulation of 
CT-1 expression. 
 
In this section the involvement of the MAPKs, PI-3 kinase as well as gp130, JAK2 
and STAT3 was analysed. 
 
3.10.1 EXPRESSION AND PHOSPHORYLATION OF GP130 IN 
EMBRYOID BODIES BY PRO-OXIDANTS AND CHEMICAL 
HYPOXIA 
 
Regulation of CT-1 expression may be mediated through phosphorylation of the 
gp130 signal transduction receptor. To assess changes in gp130 expression as well 
as gp130 phosphorylation in the presence of prooxidants and chemical hypoxia, 
semiquantitative immunohistochemistry was performed using antibodies against the 
unphosphorylated as well as the phosphorylated form of gp130. It was found that 
prooxidants as well as chemical hypoxia significantly increased gp130 expression as 
well as phosphorylation, suggesting activation of gp130-mediated signal transduction 
cascades (n = 3) (FIG. 21). 
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FIG. 21 Upregulation of gp130 protein expression and phosphorylation upon treatment of embryoid bodies with 
prooxidants or chemical hypoxia. Embryoid bodies were treated at day 4 of cell culture with either H2O2 (10 
µM), menadione (20 µM) or CoCl2 (50 µM). After 24 h gp130 protein expression and phosphorylation was 
assessed by semiquantitative immunohistochemistry using an antibody directed against unphosphorylated gp130 
or the phosphorylated form of gp130. *P < 0.05, significantly different to the untreated control. 
 
 
3.10.2 EXPRESSION AND PHOSPHORYLATION OF JAK2 AND STAT3 
IN EMBRYOID BODIES BY PRO-OXIDANTS AND CHEMICAL 
HYPOXIA 
 
By using phospho-specific antibodies it was found that treatment of EBs with 
menadione (n = 3) and CoCl2 (n = 3) led to the phosphorylation of both JAK2 and 
STAT3 (FIG. 22 A and B). To correlate the activation of JAK2 to the expression of 
CT-1, embryoid bodies were treated with the JAK-2 antagonist AG490 which 
significantly down-regulated the menadione- and CoCl2-induced up-regulation of CT-
1 (n = 3) (FIG. 23).  
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FIG. 22 Expression and activation of JAK2 and STAT3 upon incubation of embryoid bodies for 24h with either 
menadione (20 µM) or CoCl2 (50 µM). Activation was assessed by semiquantitative immunohistochemistry 
using phospho-specific antibodies. There was a significant up-regulation of JAK2 expression and activation of 
JAK2 and p-STAT3. The image show representative embryoid bodies: a, d and g, untreated; b, e and h, 
menadione-treated; c, f and i, CoCl2-treated. The bar represents 400 µM. *P < 0.05, significantly different to the 
untreated control. 
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FIG. 23 Inhibition of menadione and CoCl2 induced CT-1 expression by the JAK2 inhibitor AG 490. There was 
a significant attenuation of the effect of menadione (20 µM) and CoCl2 (50 µM) when EBs were pre-incubated 
for 2 h with 10 µM AG 490. *#P < 0.05, significantly different as indicated. 
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3.10.3 ACTIVATION OF MAPKs AND PI-3K IN EMBRYOID BODIES BY 
PRO-OXIDANTS AND CHEMICAL HYPOXIA 
 
By using phospho-specific antibodies it was found that phosphorylation of ERK1,2 
(menadione, n = 3; CoCl2,  n = 5), JNK (menadione, n = 3; CoCl2,  n = 5), p38 
(menadione, n = 4; CoCl2,  n = 4), and PI3-kinase (n = 4) occurred (FIG. 24).  
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FIG. 24 Activation of ERK1,2, JNK p38 and PI3-kinase upon incubation of embryoid bodies with either 
menadione (20 µM) or CoCl2 (50 µM). Activation was assessed by semiquantitative immunohistochemistry 
using phospho-specific antibodies. Maximum activation of ERK1,2 was achieved after 15 min; maximum 
activation of JNK was at 15 min for menadione treatment and 30 min for CoCl2 treatment; maximum activation 
of p38 was at  30 min for menadione treatment and 60 min for CoCl2 treatment; maximum activation of PI3-
kinase was at 60 min.  The bar represents 400 µm. *P < 0.05, significantly different to the untreated control. 
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3.10.4 EFFECT OF ERK1/2- (U0126), JNK-(SP600125), P38 (SKF 86002) 
AND PI3-KINASE (LY294002) INHIBITORS ON PRO-OXIDANT- 
AND CHEMICAL HYPOXIA- INDUCED CT-1 UP-REGULATION 
 
To correlate the activation of MAPK pathways and PI3-kinase to the expression of 
CT-1, embryoid bodies were treated with the ERK1,2 inhibitor UO126 (10 µM), the 
JNK inhibitor SP600125 (10 µM) the p38 inhibitor SKF86002 (10 µM) as well as the 
PI3-kinase inhibitor LY294002 (20 µM) which significantly down-regulated the 
menadione- and CoCl2-induced up-regulation of CT-1 (n = 3) (FIG. 25). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 25 Inhibition of menadione- and CoCl2-mediated upregulation of CT-1 by the ERK1,2 inhibitor UO126 (10 
µM), the JNK inhibitor SP600125 (10 µM), the p38 inhibitor SKF86002 (10 µM), and the PI3-kinase inhibitor 
LY294002 (20 µM). Embryoid bodies were treated at day 4 of cell culture with either menadione (20 µM) or 
CoCl2 in the presence of the respective inhibitor. CT-1 protein expression was assessed following 24 h by 
semiquantitative immunohistochemistry. *,#P < 0.05, significantly different as indicated. 
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3.10.5 EFFECT OF ERK1/2- (U0126), JNK-(SP600125), P38 (SKF 86002) 
INHIBITORS ON PRO-OXIDANT- AND CHEMICAL HYPOXIA- 
INDUCED HIF-1α UP-REGULATION 
 
 It has previously been shown that the MAPKs are activated under conditions of 
increased ROS production. Thus, it was necessary to find out whether inhibiting 
these kinases would affect the menadione and CoCl2 induced regulation of HIF-1α 
expression. 
 
The EBs were preincubated for 2 h with U0126 (10 µM), SP600125 (10 µM) and SKF 
86002 (10 µM) prior to adding of either menadione or CoCl2. All three inhibitors 
significantly attenuated the effect of both menadione (20 µM) and CoCl2 (50 µM) as 
shown in FIG. 26. 
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FIG. 26 Inhibition of menadione- and CoCl2-mediated upregulation of HIF-1α by the ERK1,2 inhibitor UO126 
(10 µM), the JNK inhibitor SP600125 (10 µM), the p38 inhibitor SKF86002 (10 µM). Embryoid bodies were 
treated at day 4 of cell culture with either menadione (20 µM) or CoCl2 (50 µM) in the presence of the respective 
inhibitor. HIF-1α protein expression was assessed following 24 h by semiquantitative immunohistochemistry. 
*
,#P < 0.05, significantly different as indicated. 
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3.11 EFFECT OF THE INHIBITION OF HIF-1 α ON CT-1 EXPRESSION 
 
3.11.1 EFFECT OF HIF-1α INHIBITOR (2-METHOXYESTRADIOL) ON 
PRO-OXIDANTS AND CHEMICAL HYPOXIA INDUCED CT-1 AND 
HIF-1α UP-REGULATION 
 
Our working hypothesis suggested that the ROS mediated CT-1 expression was HIF-
1α dependent. This implies that inhibition of HIF-1α would lead to inhibition of CT-1 
up-regulation by pro-oxidants and hypoxia thereby decreasing cardiomyogenesis. 
To test our theory, embryoid bodies grown from the parental CCE cell line were 
treated with the HIF-1α inhibitor 2-methoxyestradiol (2-ME) (3 µM). In corroboration 
of our working hypothesis it was apparent that in the presence of 2-ME menadione- 
and chemical hypoxia-induced upregulation of CT-1 was significantly attenuated 
(FIG. 27A) (n = 5).  Furthermore, treatment with 2-ME significantly inhibited the 
increase HIF-1α expression observed after menadione (20 µM) and CoCl2 (50 µM) 
exposure (FIG. 27B). 
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FIG. 27 Inhibition of menadione- and CoCl2-mediated upregulation of CT-1 by the HIF-1α inhibitor 2-ME (3 
µM). Embryoid bodies were treated at day 4 of cell culture with either menadione (20 µM) or CoCl2 (50 µM)    
in the presence of 2-ME. CT-1 (A) and HIF-1α (B) protein expression was assessed following 24h by 
immunohistochemistry. *,#P < 0.05, significantly different as indicated. 
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3.11.2  ABSENCE OF CARDIOMYOGENESIS AND STIMULATION OF 
CT-1 EXPRESSION IN HIF-1α-/- ES CELLS 
 
 
To proof the involvement of HIF-1α in the regulation of CT-1 expression, we made 
use of the homozygous HIF-1α-deficient HM ES cell line (Hopfl et al, 2000). In 
differentiating HIF-1α-/- ES cells cardiomyogenesis was completely absent as 
assessed by determination of the number of beating embryoid bodies (FIG. 28). The 
lack of cardiomyogenesis in the EBs derived from the HIF-1α-/- ES cells suggest the 
involvement of HIF-1α in the cardiomyogenic activities of CT-1 since it has previously 
been shown by Sauer and colleagues (2004) that CT-1 promotes cardiomyogenesis 
using a ROS dependent mechanism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 28 Cardiac cell differentiation in wt and HIF-1α-/- ES cells assessed by counting the number of beating EBs 
between day 6 and day 12. There was no cardiomyogenesis observed in the HIF-1α-/- derived EBs. There was a 
significant progressive increase in the number of EBs with beating areas in the wt cells. *P < 0.05, significantly 
different to wt embryoid bodies. 
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Moreover, as compared to wt HM-1 ES cells (FIG. 29) and ES cells of the CCE cell 
line (FIG. 12A) no upregulation of CT-1 during the time course of differentiation was 
observed (n = 5) although there was basal CT-1 protein expression. 
 
 Furthermore, the upregulation of CT-1 mRNA (FIG. 30A) (n = 6) and protein (FIG. 
30B) (n = 4) following treatment of embryoid bodies with menadione and CoCl2 was 
completely abolished in HIF-1α-/- ES cells. Taken together, our data strongly support 
the hypothesis that HIF-1α regulates CT-1 expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 29 Analysis of CT-1 expression during the time of differentiation. No upregulation of CT-1 mRNA was 
observed in HIF-1α-/- as compared to the wt which showed a similar trend as observed in CCE ES cell derived 
EBs as assessed by semiquantitative immunohistochemistry. *P < 0.05, significantly different to wt embryoid 
bodies. 
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FIG. 30 Expression of CT-1 during the time of differentiation in wt and HIF-1α-/- ES cells upon incubation with 
menadione (20 µM) and CoCl2 (50 µM) (A, B). In HIF-1α-/- ES cells no upregulation of CT-1 protein (A) and 
mRNA (B) was observed as compared to the wt. This was asssed by semiquantitative immunohistochemistry and 
real-time PCR respectively. *P < 0.05, significantly different to control in wt embryoid bodies. 
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3.12  INCREASED CARDIOMYOGENESIS IN EBS TREATED WITH 
PRO-OXIDANTS AND CHEMICAL HYPOXIA 
 
Since CT-1 promotes cardiomyogenesis, ROS- and hypoxia-mediated up-regulation 
of CT-1 in EBs should lead to the stimulation of cardiomyogenesis. To test this 
notion, EBs were treated with menadione (20 µM) and CoCl2 (50 µM) (n=3) on day 4 
of differentiation and cultivated on petriperm plates till day 8. ROS and hypoxia 
significantly increased cardiomyogenesis in comparison to control as assessed by 
determination of the number of beating embryoid bodies (FIG. 31).  
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FIG. 31 Cardiomyogenesis in CCE ES cells.  Incubation with menadione (20 µM) and CoCl2 (50 µM) (n=3) 
lead to a significant increase in the number of beating EBs as compared to control. *,P < 0.05, significantly 
different as indicated. 
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In order to find out whether ROS was involved in the chemical hypoxia induced 
cardiomyogenesis, plated EBs were preincubated with either the free radical 
scavengers vitamin E (20 µM) and NMPG (20 µM) or the specific NADPH oxidase 
inhibitor apocynin (10 µM) for 2 h prior to adding CoCl2. The effect of CoCl2 was 
significantly attenuated by free radical scavengers vitamin E (20 µM) (n=3), NMPG 
(20 µM) (n = 4) and NADPH oxidase inhibitor apocynin (10 µM) (n = 4) (FIG. 32), 
indicating that ROS was involved.  
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FIG 32  Inhibition of cardiomyogenesis in CCE ES cells. The effect induced by CoCl2 was significantly 
abolished when EBs were preincubated with vitamin E, NMPG and apocynin. This was evaluated by counting 
the number of spontaneously contracting embryoid bodies. *,#P < 0.05, significantly different as indicated. 
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3.13  CELLULAR LOCALISATION OF CT-1 PRE- AND POST-
STIMULATION WITH PRO-OXIDANT AND CHEMICAL HYPOXIA 
 
In order to find out where CT-1 is localised in the cells pre- and post stimulation, eight 
days old EBs with beating foci (cardiomyocytes) were dissociated into single cells 
with 1mg/ ml collagenase and plated on coverslips in 24 wells cell culture plates. 
Four days after dissociation, cells were treated for 4h with either menadione (20 µM) 
or CoCl2 (50 µM) and stained for CT-1 and against α-actinin to identify 
cardiomyocytes. There was up-regulation and translocation of CT-1 from the 
cytoplasm to the nucleus in cell treated with menadione and CoCl2 in comparison to 
control (FIG. 33). 
 
 
 
 
FIG. 33 Induction of nuclear translocation of CT-1 in cardiomyocytes (b, c) as well as non-cardiomyoctes (e, f) 
after treatment with 20 µM Menadione (b, e) and 50 µM CoCl2 (c, f).
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4 DISCUSSION 
                                              
Exposure of cells to ROS such as O2.− and H2O2 has been associated to a variety of 
physiological and pathological events [Cross et al, 1987; Miller and Britigan, 1995]. 
The cellular consequences of oxidant exposure, as well as the relative importance of 
different cellular antioxidant systems in protecting cells from such exposures, varies 
with both the nature of the oxidant species generated and the intracellular and/or 
extracellular location of generation [Fujimoto et al, 1990; Miller and Britigan, 1995].  
 
The aim of the present study was to analyse the role of redox signalling for the 
expression of CT-1 in differentiating mouse ES cells in response to pro-oxidants and 
hypoxia and to find out whether HIF-1α is involved in the ROS dependent regulation 
of CT-1. To induce changes in the intracellular redox state, we incubated the mouse 
ES cell-derived EBs with either H2O2, menadione (pro-oxidant), CoCl2 (chemical 
hypoxia) or nitrogen gas (physiological hypoxia – 1% O2). Menadione is a quinone 
which has been widely used to induce cellular oxidative stress [Chen and 
Cederbaum, 1997; Han et al, 2002; Kawasaki et al, 2004; Mauzeroll and Bard, 2004]. 
Quinones form an important group of substrates for flavoenzymes and  can undergo 
either one-electron reduction, producing semiquinone radicals, or two-electron 
reduction, resulting in hydroquinones. In the presence of O2 the semiquinones and 
hydroquinones are transformed back to the mother quinone (redox-cycle), thereby 
generating O2.- which is transformed to the more stable H2O2. CoCl2 has been widely 
used to mimic hypoxia and has been previously shown to induce an increase in 
intracellular ROS concentration and up-regulation of HIF-1α [Liu et al, 1999; 
Chachami et al, 2004; BelAida et al, 2004]. 
 
We found that the up-regulation of CT-1 in differentiating mouse ES cells by pro-
oxidants and hypoxia depends on ROS, gp130/JAK2/STAT3 as well as MAPKs, PI-
3K and HIF-1α. Furthermore, NADPH-oxidase was found to be the source of ROS 
generation (see FIG. 35).                 .                  
 
Very often, reduction or oxidation of protein redox active groups is a key event in 
enzymatic reactions. The function of most proteins crucially depends on the redox 
state of the solution [Ullmann and Knapp 1999]. During recent years, considerable 
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evidence has been accumulated to show that the intracellular redox state can 
regulate cell proliferation, differentiation, cellular growth and development [Hutter et 
al, 1997; Smith et al, 2000; Sauer et al, 2001; Droege 2002]. ROS are produced after 
activation of cell surface receptors, such as cytokine- and G protein-coupled 
receptors. ROS generated in response to cytokine receptor activation are implicated 
in the control of apoptotic pathways. Conversely, ROS generated in response to 
activation of G protein-coupled receptors are involved in triggering cell proliferation 
and hypertrophy. 
Sauer and colleagues (1999, 2000) showed that differentiation of stem cells into 
cardiomyocytes is critically regulated by exogenous as well as endogenous ROS. 
Changes in the intracellular redox state initiate various signalling pathways and 
regulate the transcriptional and post transcriptional events that control gene 
expression [Haddad 2002]. Napoli and colleagues (2001), showed by using cDNA 
microarray, that about 100 genes are induced in response to oxidant stress. Kokura 
and colleagues (1999) showed that changes in the endothelial cell redox state cause 
transcriptional-independent and transcriptional-dependent surface expression of 
different endothelial adhesion surface molecules, which leads to neutrophil-
endothelial adhesion. ROS are involved in the signalling cascade for cardio-
protection induced by brief exposure to volatile anaesthetic, a procedure known as 
anaesthetic preconditioning. Up-regulation of transcription factors such as NF-kB and 
AP-1 occur after treatment with H2O2 [Schreck, Rieber and Baeuerle, 1991].  
 
Hypoxia is a (patho-) physiological situation occurring during conditions, where 
increased expression of CT-1 has been reported: (a) during cardiac diseases like 
angina pectoris, cardiac infarction and heart failure [Freed et al, 2003]; (b) in the 
embryonic heart where the heart mass increases through cardiac cell hyperplasia 
[Wikenheiser et al, 2005]; (c) during the growth of ES cells within the 3-dimensional 
tissue of embryoid bodies [Wartenberg et al, 2001]. Recently, it has been 
demonstrated that hypoxia is associated with increased ROS generation produced 
either through the mitochondrial respiratory chain or NADPH-oxidase activity [Wolin 
et al, 2005]. Elevated ROS are known to occur in cardiac infarction and are 
suspected to cause ischemia-reperfusion injury [Berg et al, 2005].  
Although hypoxia has been previously demonstrated to induce CT-1 expression 
[Hishinuma et al, 1999], the underlying signaling cascades have not been clarified 
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nor has any connection between hypoxia, ROS generation and CT-1 expression 
been established. In differentiating ES cells within EBs hypoxia occurs [Wartenberg 
et al, 2001] and endogenous generation of ROS via NADPH-oxidase [Sauer et al, 
1999; Sauer et al, 2000] has been previously corroborated, which led to the working 
hypothesis of the present study that hypoxia and ROS may regulate CT-1 
expression. Treatment of EBs with vitamin E which is a free radical scavenger led to 
the down-regulation of CT-1 and HIF-1α expression. Vice versa pro-oxidants as well 
as physiological and chemical hypoxia up-regulated CT-1 as well as HIF-1α protein 
and mRNA expression. Furthermore, either menadione treatment or chemical 
hypoxia resulted in increased ROS generation with subsequent up-regulation of 
ROS-generating NADPH-oxidase, supporting the notion that under conditions of pro-
oxidant incubation and hypoxia the same ROS-mediated signaling pathways are 
triggered. The up-regulation of HIF-1α by exogenously applied ROS and hypoxia is in 
line with its role in the control of cellular oxygen homeostasis. Many studies reported 
the up-reguation of HIF-1α by exogenously applied ROS and hypoxia [Iyer et al, 
1997; Chandel et al, 1998; Duranteau et al, 1998; Chandel et al, 2000; Goda et al, 
2003], consequently leading to the regulation of many other redox sensitive genes. 
Elevated ROS levels during hypoxia have been previously shown to occur in 
pulmonary myocytes [Marschall et al, 1996], cardiac myocytes, Hep3B cells, HeLa 
cells [Chandel et al, 1998] as well as adipocytes [Carriere et al, 2003], the sources 
being either the mitochondrial respiratory chain or NADPH-oxidase. These ROS may 
regulate the so far not quite defined non-hypoxic pathway of HIF- 1α stabilization, 
translocation and activation [Haddad, 2002; Haddad and Harb, 2005]. On the basis of 
the properties of NOX oxidases it has been recently proposed that hypoxia could 
cause an acute increase in ROS production by augmenting rates of electron transport 
to cytochrome b558, and this could occur through hypoxia-promoting oxidase 
activation and/or increasing the availability of its NADH or NADPH substrates [Wolin, 
Ahmad and Gupte, 2005]. The data of the present study clearly point towards a 
distinct role of NADPH-oxidase-derived ROS in the regulation of CT-1 expression in 
ES cells (see FIG. 35) since inhibition of NADPH-oxidase by apocynin as well as DPI 
abolished pro-oxidant and chemical hypoxia-mediated induction of CT-1. The 
involvement of ROS in the regulation of CT-1 expression was further validated by 
experiments demonstrating that the effects observed with the pro-oxidant menadione 
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and chemical hypoxia (CoCl2) were significantly attenuated when EBs were pre-
incubated with the free radical scavengers vitamin E and NMPG.  
The regulation of cytokine expression by HIF-1α and ROS has been recently 
discussed [Haddad and Harb, 2005]. Expression of cytokines is generally associated 
to states of hypoxia, ROS generation and inflammation, i.e. patho-physiologic 
situations that require an immunological response as well as protection from tissue 
injury. Previously, stimulation of mRNA expression as well as secretion of IL-6 in 
response to exposure with pro-oxidants have been shown [Kosmidou et al, 2002; 
Haddad et al, 2002; Kida et al, 2005] and may act in paracrine as well as autocrine 
manner, thereby activating a loop mechanism disposed to stimulate the cell´s IL-6 
receptors. CT-1 is a naturally occurring protein member of the interleukin (IL)-6 
cytokine family and signals through the gp130/leukemia inhibitory factor receptor 
(LIFR) heterodimer. The formation of gp130/LIFR complex triggers the auto/trans-
phosphorylation of associated Janus kinases, leading to the activation of Janus 
kinase/STAT and MAPK (ERK1 and -2) signalling pathways [Igaz, Tóth and Falus, 
2001; Zvonic et al, 2004].  
 In this respect, our data demonstrated stimulation of gp130 protein expression as 
well as phosphorylation by pro-oxidants and chemical hypoxia, and downstream 
activation of several members of the previously described CT-1 activated signal 
transduction cascade, i.e. the MAPKs, ERK1,2, JNK, p38 as well as PI3-kinase which 
indeed suggests activation of the CT-1-mediated signalling cascade by ROS (see 
FIG. 35). Mitogen-activated protein kinase (MAPK) signaling pathways consist of a 
sequence of successively acting kinases that ultimately result in the dual 
phosphorylation and activation of terminal kinases such as p38, JNKs, and ERKs 
[Widman et al, 1999]. The MAPK signaling cascade is initiated in cardiac myocytes 
by G protein–coupled receptors (angiotensin II, endothelin-1, and adrenergic 
receptors), receptor tyrosine kinases (insulin-like growth factor, transforming growth 
factor-ß, and fibroblast growth factor receptors), CT-1 (gp130 receptor), and by stress 
stimuli [Sugden et al, 1998]. The requirement of ROS for the functioning of the MAPK 
pathways has been demonstrated in a variety of studies. Our data are in line with 
reports that hypoxia and exogenously applied ROS lead to the activation of the 
MAPKs (p38, JNK, ERK1,2) and PI-3K [Baas and Berk, 1995; Kulisz et al, 2001; 
Schäfer et al, 2003]. Menadione [Czaja, Liu and Wang, 2003; Dabrowski et al, 2000] 
as well as CoCl2 [Liu et al, 1999; Yan et al, 2005] have been reported to activate the 
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MAPKS. Furthermore, there was significant up-regulation and activation of gp130R 
as well as JAK2 and STAT3. Consequently, the data of the present study 
demonstrated that inhibition of all investigated MAPK pathways, PI3-kinase as well 
as the JAK/STAT pathway, abolished the pro-oxidant- and hypoxia-mediated 
increase in CT-1 and HIF-1α expression. The present study clearly shows redox 
sensitivity of ERK1,2, JNK as well as p38, which link the observed increase in 
intracellular ROS generation to the signalling cascades involved in initiation of CT-1 
gene regulation, promoting for example cardiomyocytes survival [Sheng et al, 1996; 
Sheng et al, 1997; Latchman, 1999; Craig et al, 2001; NG et al, 2002; Freed et al, 
2003] and proliferation [Pennica et al, 1995; Sauer et al, 2004]. 
 
The mouse CT-1 gene has been recently isolated. It constitutes 5.4 kilobases (kb) in 
length and consists of three exons and two introns. When nucleotide sequences of 
the coding regions of exons were compared with those of human, it was observed 
that exon 1, 2 and 3 share 96%, 84% and 81% homology, respectively. Interestingly, 
potential binding sites for several ubiquitous transcription factors including Nkx2,5, 
NF-IL6, CREB, GATA, AP-1, and most important, HIF-1α were present in the 5´-
flanking region extending 2174-bp upstream from the transcription initiation site 
[Funamoto et al, 2000]. The presence of the HIF-1α binding site on the CT-1 gene 
accentuates the notion of the present study of CT-1 regulation by signal transduction 
pathways that involve HIF-1α.  If CT-1 expression is indeed regulated by HIF-1, 
absence of hypoxia- and pro-oxidant-mediated up-regulation of CT-1 should be 
anticipated under conditions of either pharmacological or genetic inactivation of the α 
subunit of HIF-1. This was investigated by either a pharmacological approach using 
2-methoxyestradiol (2-ME), which has been recently shown to downregulate HIF-1α 
at the posttranscriptional level and inhibits HIF-1-induced transcriptional activation of 
VEGF expression [Mabjeesh et al, 2003], or by ES cells homozygous deficient for 
HIF-1α [Hopfl et al, 2002] (see FIG. 34). 2-ME significantly inhibited the effect of 
menadione and chemical hypoxia (CoCl2) on the expression of CT-1 and HIF-1α in 
differentiating EBs. Although basal mRNA and protein expression of CT-1 was found 
in HIF-1α-/- cells, up-regulation during the time course of ES cell differentiation as 
occurring in wt cells was not observed, and cardiomyogenesis was completely 
absent. The absence of cardiomyogenesis in the HIF-1α-/- ES cells indicates the 
importance of redox signalling pathway involving CT-1 and HIF-1α in the growth and 
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development of cardiomyocytes during embryogenesis, since treatment of CCE S103 
ES cells, which have intact HIF-1α gene, with menadione and CoCl2 lead to 
significant increase in cardiomyogenesis in comparison to control as observed by 
increase in number of beating (contracting) EBs. This effect was inhibited when the 
EBs were pre-incubated with free radicals scavengers and NADPH-oxidase inhibitor, 
indicating the involvement of ROS. Furthermore, pro-oxidants as well as chemical 
hypoxia failed to up-regulate CT-1 in HIF-1α-/- ES cells both at the protein and mRNA 
levels which clearly demonstrate regulation of CT-1 expression by HIF-1α.  
             
FIG. 34 Inhibition of ROS-dependent CT-1 up-regulation by 2-Methoxyestradiol (HIF-1a inhibitor) and through 
knockout of HIF-1α gene. 
 
Although the classical view of HIF-1 regulation proposed stabilization of HIF-1α 
under hypoxic conditions and down-regulation at normoxia by process of pVHL-
mediated ubiquitin-proteasome pathway, mechanisms of HIF-1α stabilization under 
normoxic conditions have been recently proposed [Lee et al, 2004]. These non-
hypoxic pathways are utilized by many growth factors and cytokines, including 
insulin-like growth factors [Feldser et al, 1999], transforming growth factor and 
platelet-derived growth factor [Gorlach et al, 2001] and IL-1ß [Hellwig-Burgel et al, 
1999], which are all known to utilize ROS as signalling molecules within their signal 
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transduction cascade. In this regard it was demonstrated that inhibition of ROS 
generation abolished hormone and growth factor-mediated increase in HIF-1α 
expression [Richard et al, 2000]. The data of the present study demonstrate ROS 
generation under conditions of either chemical or physiological hypoxia which was 
recently also reported to occur in intrapulmonary arteries of mice [Liu et al, 2005], in 
skeletal muscle [Zuo and Clanton, 2005] and in human hepatoma cells [Chandel et 
al, 2000]. This was underscored by the observation that oxygen sensing during 
hypoxia is dependent on mitochondrial-generated ROS [Brunelle et al, 2005; 
Emerling et al, 2005].    
 
Another observation which has as of now not yet been reported, was the 
translocation of CT-1 from the cytoplasm to the nucleus in cells treated with pro-
oxidant or chemical hypoxia. This nuclear translocation process was complete 
between two to four hours after stimulation in cardiomyocytes as well as non-
cardiomyocytes. Whether nuclear translocation is required for CT-1-mediated gene 
activation remains to be determined. 
 
Regulation of CT-1 expression by HIF-1α and ROS sounds reasonable in light of its 
biological function in inhibiting cardiac cell apoptosis, promoting cardiac cell 
hypertrophy and stimulating embryonic cardiac cell differentiation and proliferation, 
which are phenomena occurring under conditions of hypoxia and/or ROS-mediated 
inflammation. The investigation of the physiological microenvironment that regulates 
CT-1 expression will not only assist to unravel the role of CT-1 in cardiac hypertrophy 
and cardiac repair in the infarcted heart, but also give clues to the understanding of 
the mechanisms of cardiac cell hyperplasia in the embryonic heart and 
cardiomyogenic differentiation of ES cells.  
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FIG. 35  Scheme of the proposed signal transduction cascade activated by ROS and hypoxia.  Either hypoxia 
(initiating elevated ROS generation) or exogenous addition of ROS induces phosphorylation of gp130 and 
initiates a feed-forward cycle of NADPH-oxidase activity and expression. ROS generated by NADPH-oxidase 
act as signalling molecules within the CT-1/gp130 signalling cascade which finally results in HIF-1 upregulation 
and stimulation of CT-1 expression. 
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5 SUMMARY 
 
Cardiomyogenesis in differentiating mouse embryonic stem (ES) cells is promoted by 
cardiotrophin-1 (CT-1), a member of the IL-6 interleukin superfamily and acts through 
the gp130 cytokine receptor. It was shown that prooxidants (menadione, hydrogen 
peroxide) as well as chemical (CoCl2) and physiological (1% O2) hypoxia increased 
CT-1 as well as HIF-1α protein and mRNA expression in embryoid bodies, indicating 
that CT-1 expression is regulated by reactive oxygen species (ROS) and hypoxia. 
Treatment with either prooxidants or chemical hypoxia increased gp130 
phosphorylation and protein expression of NADPH-oxidase subunits p22-phox, p47-
phox, p67-phox, as well as Nox-1 and Nox-4 mRNA. Consequently, inhibition of 
NADPH-oxidase activity by diphenylen iodonium chloride (DPI) and apocynin 
abolished prooxidant- and chemical hypoxia-induced up-regulation of CT-1 and HIF-
1α. Prooxidants and chemical hypoxia activated ERK1,2, JNK and p38 as well as 
PI3-kinase, JAK2 and STAT3. The pro-oxidant and CoCl2-mediated up-regulation of 
CT-1 and HIF-1α was significantly inhibited in the presence of the ERK1,2 antagonist 
UO126, the JNK antagonist SP600125, the p38 antagonist SKF86002, the PI3-
kinase antagonist LY294002, the JAK-2 antagonist AG490 as well as in the presence 
of free radical scavengers. Moreover, developing embryoid bodies derived from HIF-
1α-/--ES cells lack cardiomyogenesis, and prooxidants as well as chemical hypoxia 
failed to upregulate CT-1 expression. Treatment of cells obtained by collagenase 
dissociation of beating EBs with pro-oxidants and chemical hypoxia resulted in the 
translocation of CT-1 into the nucleus within 2-4 h. In summary our data demonstrate 
that CT-1 expression in ES cells is regulated by ROS and HIF-1α and imply a crucial 
role of CT-1 in survival and proliferation of ES cell-derived cardiac cells. The 
importance of CT-1 nuclear transport to CT-1 mediated gene expression is still to be 
determined. 
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5.1 ZUSAMMENFASSUNG 
 
Die Kardiomyogenese in differenzierenden embryonalen Stammzellen der Maus wird 
durch Cardiotrophin-1 (CT-1) gefördert, einem Mitglied der IL-6 Interleukin 
Superfamilie, das seine Signale durch den gp130 Rezeptor vermittelt. Es wurde 
gezeigt, dass sowohl Prooxidantien (Menadione, Wasserstoffperoxid) als auch 
chemische (CoCl2) und physiologische Hypoxie (1% O2) die CT-1 sowie HIF-1α 
Protein- und mRNA-Expression in den Embryonalkörperchen erhöhen, was zeigt, 
dass die CT-1 Expression durch reaktive Sauerstoff- Spezies  (ROS) und Hypoxie 
geregelt wird. Die Behandlung mit Prooxidantien oder mit chemischer Hypoxie 
erhöhte die gp130 Phosphorylierung und Proteinexpression der NADPH-Oxidase-
Untereinheiten p22-phox, p47-phox, p67-phox, sowie die mRNA-Expression von 
Nox-1 und Nox-4. Dementsprechend führte die Hemmung der NADPH-Oxidase 
Aktivität durch Diphenylen Iodonium Chloride (DPI) und Apocynin zur Aufhebung der 
durch Prooxidantien und chemische Hypoxie abhängigen Steigerung der CT-1 und 
HIF-1α Expression. Prooxidantien und chemische Hypoxie aktivierten ERK1,2, JNK 
und p38 sowie PI3-kinase, JAK2 und STAT3. Die Menadione- und CoCl2-vermittelte 
Steigerung von CT-1 and HIF-1α wurde in Anwesenheit des ERK1,2 Antagonisten 
UO126, des JNK Antagonisten SP600125, des p38 Antagonisten SKF86002, des 
PI3-Kinase Antagonisten LY294002, des JAK-2 Antagonisten AG490 sowie in 
Anwesenheit von freien Radikalfängern signifikant gehemmt. Außerdem zeigten die 
aus HIF-1α-/- ES Zellen entwickelten Embryonalkörperchen keine Kardiomyogenese, 
und die Behandlung mit Prooxidantien sowie chemischer Hypoxie führte nicht zu 
einer  Steigerung der CT-1 Expression. Nach Kollagenaseverdau der schlagenden 
Areale aus EBs wurden die vereinzelten Zellen mit Menadione und CoCl2 behandelt. 
Dies führte innerhalb von 2-4 Stunden zum Transport von CT-1 in den Kern.  
Zusammenfassend zeigen unsere Daten, dass die CT-1 Expression in den ES Zellen 
von ROS und HIF-1α reguliert wird und deuten eine entscheidende Rolle von CT-1 
im Überleben und der Proliferation der ES-abgeleiteten Herzzellen an. Die 
Bedeutung des CT-1 Kerntransportes für die CT-1- vermittelte Genexpression muss 
noch festgestellt werden. 
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